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ABSTRACT 
Human immunodeficiency virus (HIV) associated neurocognitive disorders 
(HAND) affect 50% of individuals with HIV. HAND is characterized by cognitive and 
functional impairment and is diagnosed through neuropsychological assessment. The use 
of performance validity tests (PVT) is recommended to determine the credibility of 
cognitive profiles during neuropsychological testing. However, little is known about the 
utility of PVTs within an HIV+ population. The objective of the present study was to 
compare the base rate of failure on embedded validity indicators (EVIs) between 
individuals diagnosed with HAND, neurocognitively normal individuals with HIV, 
undergraduate controls, and undergraduates asked to feign cognitive impairment. The 
relationship between EVI failure and neurocognitive performance, as well as self-
reported depressive symptoms, was also explored. Cumulative EVI failure produced good 
classification accuracy within the student sample, reaffirming their utility in detecting 
invalid performance. As predicted, individuals with more severe HAND diagnoses (i.e., 
HIV-associated dementia and mild cognitive impairment) failed more EVIs than 
neurocognitively normal individuals. Further, as neurocognitive test performance 
decreased, cumulative EVI failures increased. Although directionality of this finding 
could not be determined (i.e., do low scores reflect non-credible responding or are EVI 
failures false positives in individuals with genuine impairment?), monitoring performance 
validity might help explain the well-known fluctuation in cognitive performance over 
time in the HAND population. There was no relationship between the number of EVIs 
failed and self-reported depressive symptoms or severity, ruling out a commonly 
discussed confounding variable in PVT research. 
 vi 
ACKNOWLEDGEMENTS 
I would like to thank all the individuals at the Southern Alberta Clinic who agreed 
to have their neurocognitive data used for research purposes. I hope this data will be used 
to help provide you with the most appropriate and optimal treatment. I would also like to 
thank all the undergraduate students who devoted their time to the present study.  
Thank you to Dr. Erdodi for supporting me throughout the conceptualization, 
execution, and writeup of this thesis project. Thank you for compromising with me, 
sharing your knowledge, and encouraging my work-life balance. Additionally, thank you 
for your patience and time during incredibly tight timelines. 
This project would not have been possible without the support of Dr. Fujiwara, 
Dr. Power, and Dr. Gill. They were willing to share data collected over multiple years for 
this project and I hope it provides a platform to begin measuring performance validity in 
HIV research. 
I would like to thank my committee members, Dr. Christopher Abeare and Dr. 
Eleanor Maticka-Tyndale for their enthusiasm about my project, asking difficult 
questions, and their constructive criticism.  
I don’t think I would have been able to finish the past two years without my 
incredible social network – my family and friends. Specifically, late nights with Tara 
McAuley and Brandon Zuccato provided so much support and joy during difficult times. 
I am also very grateful for my friends that have offered laughter, guidance, and relief 
including Amy Tran, Sanya Sagar, John Howland, and Christie Kimber. Lastly, I would 
like to thank my family for their unconditional love. 
  
vii 
TABLE OF CONTENTS 
 
DECLARATION OF CO-AUTHORSHIP               iii 
ABSTRACT                    v 
ACKNOWLEDGEMENTS                 vi 
LIST OF ABBREVIATIONS              viii 
 
Chapter I                     1 
 Introduction                    1 
  Performance Validity Testing                 1 
  HIV-Associated Neurocognitive Disorders               9 
  Objective                 17 
 
Chapter II                   20 
 Methods                  20 
  Participants                 20 
  Measures                 22 
  Statistical Analysis                27 
 
Chapter III                   30 
 Results                   30 
  Data Cleaning                            30 
  Testing of Assumptions                          30 
  Main Analyses                                 31 
 
Chapter IV                   48 
 Discussion                   48 
  Determining EVI Cutoffs Using the Student Sample            48 
  Hypothesis 1                 51 
  Hypothesis 2                 52 
  Hypothesis 3                 54 
  Limitations                 55 
  Future Directions                56 
  Summary and Conclusions               57 
 
REFERENCES                  59 
APPENDIX A                  85 
APPENDIX B                     86 
APPENDIX C                   88 
VITA AUCTORIS                  90 
  
viii 
 
LIST OF ABBREVIATIONS 
AIDS   Acquired Immunodeficiency Syndrome 
ANI   Asymptomatic Neurocognitive Impairment 
ANOVA  Analysis of Variance 
AUC   Area Under the Curve 
BRFail   Base Rate of Failure 
cART   Combination Antiretroviral Therapy 
CD4   Cluster of Differentiation 4 
CNS   Central Nervous System 
CONT   Undergraduate Controls 
EXPMAL  Experimental Malingering Condition 
EVI    Embedded Validity Indicator 
FMS   Failure to Maintain Set 
GPB   Grooved Pegboard Test 
HAD   HIV-Associated Dementia 
HAND   HIV-Associated Neurocognitive Disorder 
HDS   HIV Dementia Scale 
HIV    Human Immunodeficiency Virus 
HIV+   Individuals Living with HIV 
HDS   HIV Dementia Scale 
HVLT-R  Hopkins Verbal Learning Test – Revised  
MND   HIV-Associated Mild Neurocognitive Disorder 
NN   Neurocognitively Normal Individuals Diagnosed with HIV 
  
ix 
PHQ-9   Patient Health Questionnaire  
PVT   Performance Validity Test 
SAC   Southern Alberta Clinic 
SD   Standard Deviation 
SDMT   Symbol Digit Modalities Test 
TBI   Traumatic Brain Injury 
TMT   Trail Making Test 
WCST   Wisconsin Card Sorting Test 
WCT   Word Choice Test 
WRAT-4  Wide Range Achievement Test (4th Version)
  
1 
Chapter I 
Introduction 
Performance Validity Testing 
 In neuropsychological assessment, accurate diagnosis and appropriate treatment are 
dependent upon the valid presentation of an examinee’s neuropsychological functioning. Often 
lacking objective biomarkers, a neuropsychologist’s decisions are based on a combination of 
self-reported symptoms, behavioural observations, and performance on objective tests of 
cognitive ability (Carone, 2015). However, there is a growing awareness that neuropsychological 
test performance is not always an accurate reflection of an examinee’s true ability. Performance 
validity tests (PVTs) were developed to assess whether (or the extent to which) the scores on 
neuropsychological tests are an accurate reflection of the examinee’s neurocognitive functioning 
(Boone, 2013; Larrabee, 2014b).   
 PVT failures are commonly interpreted as evidence of non-credible responding and alert 
the assessor that test results may be invalid and should be interpreted with caution. Non-credible 
performance, as indicated by PVT failure, may explain up to 50% of variance on 
neuropsychological testing (Green, Rohling, Lees-Haley, & Allen, 2001; Meyers, Volbrecht, 
Axelrod, & Reinsch-Boothby, 2011), has produced large effect sizes (d = 1.0), and ultimately 
diminished study replicability (Larrabee, 2012).        
 Brief history. In 1912, Sir John Collie discussed malingering as a significant concern 
within medical practice (as referenced in Greher & Wodushek, 2017). This marked the first 
recorded instance of validity concerns within a health care setting. By the 1940’s, Andre Rey had 
developed the Rey-15 item and dot counting tests. These were the first indicators of performance 
validity in neuropsychological testing (Frederick, 2003).  
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In the 1990’s, PVT development rapidly increased (Carone, 2015). This growth was a 
consequence of the gradual realization that the clinical judgment of psychologists and 
psychiatrists about malingering during expert witness testimonies were often unreliable and 
inaccurate (Faust, Hart, Guilmette, & Arkes, 1988a, 1988b; Heaton, Smith, Lehman, & Vogt, 
1978). In addition, it was during this time period that the first modern book on malingering was 
published (Rogers, 1988). Validity testing has since extended beyond neuropsychological 
testing. Objective measures of the under- and over-reporting of symptoms have been 
incorporated into multiple psychological inventories and structured interviews, such as the L and 
K scales in the Minnesota Multiphasic Personality Inventory (Ben-Porath & Tellegen, 2008) as 
well as the infrequent and negative impressions subscales of the Personality Assessment 
Inventory (Morey, 2007).      
 Recent literature suggests that the majority of assessors have incorporated measures of 
performance validity into their practices (Dandachi-FitzGerald, Merckelbach, & Ponds, 2017; 
Jung & Reidenberg, 2007). In 2015, over 92% of 316 neuropsychologists surveyed reported 
“often” or “always” using a PVT to detect non-credible performance (Martin, Schroeder, & 
Odland, 2015). This is a dramatic increase from a 2007 study reporting only 52% of 
neuropsychologists frequently used PVTs (Sharland & Gfeller, 2007). The importance of PVTs 
in clinical practice has been highlighted by several professional organizations. The National 
Academy of Neuropsychology and the American Academy of Clinical Neuropsychology have 
declared that PVTs are “medically necessary” and “important in all evaluations” (Board of 
Directors, 2007; Bush et al., 2005).      
 Invalid performance. Concerns of non-credible presentation vary across clinical 
populations and settings. Base rate of failure (BRFail) indicates the proportion of individuals 
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within a population who fail a PVT. BRFail on validity tests during neuropsychological exams are 
highest for cases involving personal injury, workers compensation, criminal justice, and diseases 
lacking clear neuropathological biomarkers (Mittenberg, Patton, Canyock, & Condit, 2002). For 
example, chronic pain patients with financial incentive to perform poorly and individuals in 
criminal forensic settings have non-credible performance rates as high as 50% (Ardolf, Denney, 
& Houston, 2007; Greve, Ord, Bianchini, & Curtis, 2009). In psychoeducational evaluations of 
ADHD where external incentives such as medication and academic accommodations are present, 
25-50% of examinees are believed to exaggerate their deficits (Marshall et al., 2010; Suhr, 
Hammers, Dobbinsbuckland, Zimak, & Hughes, 2008; Sullivan, May, & Galbally, 2007).  
 Motivation to exaggerate or feign deficits is not the only causal mechanism behind 
invalid performance. In settings without identifiable external incentives or in diseases with 
objective biomarkers, BRFail are estimated around 10% (Mittenberg et al., 2002). Other 
explanations may include emotional distress, somatic concerns, fatigue, pain, sensory 
disturbances, and limited English proficiency (Erdodi, Seke, et al., 2017; Erdodi, Nussbaum, 
Sagar, Abeare, & Schwartz, 2017; Erdodi et al., 2016;  Greher & Wodushek, 2017, Whiteside et 
al., 2010).  Other psychological diagnoses that can increase the risk of PVT failure include 
factitious disorder, oppositional behaviour, and personality disorders (Carone, 2015).  
It is worth noting that invalid performance and genuine impairment are not mutually 
exclusive. In child custody cases, up to 98.3% of parents pass PVTs (Flaro, Green, & Robertson, 
2007). In other words, external incentive to appear cognitively intact on neuropsychological tests 
dramatically reduces BRFail. Interestingly, in situations without external incentive to appear 
cognitively intact or impaired, BRFail remains relatively high. For example, the cognitive 
functioning of undergraduate students is typically higher than average. However, while 
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completing neuropsychological tests for research purposes, 37% failed at least 1 PVT (An, 
Kaploun, Erdodi, & Abeare, 2017). Thus, it appears that the absence of an apparent external 
incentive to perform poorly is not equivalent to the presence of incentives to do well.   
 Terminology. The language surrounding validity tests has evolved since their initial 
conception (Greher & Wodushek, 2017). Originally, PVTs were believed to detect malingering 
(Slick, Sherman, & Iverman, 1999).  Malingering is the fabrication or intentional exaggeration of 
symptoms motivated by secondary external incentives (American Psychiatric Association, 2013).  
Based on criteria proposed by Slick et al. (1999), malingering could be identified and further 
classified according to the level of confidence associated with the diagnosis (e.g. probable, 
possible, or definite). It has since become clear that, although secondary gain and ligation may 
motivate an examinee to perform poorly, intent cannot be definitively known. In turn, PVT 
failure was gradually re-labeled as “poor effort” (Van Dyke, Millis, Axelrod, & Hanks, 2013).  
However, effort remains an ill-defined construct, and carries residual connotations of intent (i.e., 
“not trying hard enough”). Moreover, simulating poor effort produces activation peaks in the 
same cortical regions as full effort conditions on the Word Memory Test (Larsen, Allen, Bigler, 
Goodrich-Hunsaker, & Hopkins, 2010). Thus, when effort is quantified using a measure of 
neural activation, no differences are observed between those intentionally performing poorly and 
those trying their best. There may even be a unique pattern of neural activation that occurs while 
being deceptive (Kireev, Korotkov, Medvedeva, & Medvedev, 2013), further supporting the idea 
that suppressing true ability level while trying to avoid detection likely requires significant 
mental energy (i.e., effort). Since many neuropsychological tests begin with statements like “try 
your best” or “give your best effort”, failing PVTs can be conceptualized as non-compliance 
with instruction (Slick & Sherman, 2013).          
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 Since 2003, the preferred terminology used to describe PVT failure has been suboptimal, 
non-credible, or invalid performance (Boone & Lu, 2003). While still communicating that 
neuropsychological test scores may not reflect true cognitive ability, “non-credible” does not 
imply etiology (e.g. motivation or volition). Additionally, this language allows the conclusion to 
be objective and data-driven, while the clinician remains unbiased (Rickards, Cranston, Touradji, 
& Bechtold, 2017).  
 Free-standing vs. embedded. By design, there are two types of PVTs: free-standing 
(stand-alone) and embedded.  Free-standing PVTs are independently administered and their 
primary purpose is to estimate the credibility of a response set. Although they appear to measure 
neurocognitive performance, free-standing PVTs are largely insensitive to brain function and 
give little-to-no insight into cognitive ability (Greher & Wodushek, 2017).  Commonly used 
free-standing PVTs include the Rey-15 item Test (Rey, 1964), Test of Memory Malingering 
(TOMM; Tombaugh, 1996), and the Word Choice Test (WCT; Martin et al., 2015; Pearson, 
2009). Forced choice recognition is the most commonly utilized paradigm for free-standing 
PVTs (Bigler, 2014). In a forced-choice recognition task, an examinee is presented with a set of 
stimuli. Later, when target and foil(s) are presented, the examinee is instructed to identify the 
previously presented stimulus (Pankratz, 1983). However, one significant limitation of free-
standing PVTs is their extension of overall assessment time without contributing any information 
regarding the examinee’s current cognitive functioning (Rickards et al., 2017).  
 Unlike free-standing PVTs, embedded validity indicators (EVIs) are derived from 
traditional tests of cognitive ability and therefore, add no extra administration time. As such, they 
allow the simultaneous assessment of performance validity and neuropsychological functioning 
throughout the testing session. At sufficiently conservative cutoffs, EVIs are insensitive to 
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neurological diseases and are indicative of non-credible performance rather than cognitive 
deficit. EVIs are difficult to identify as PVTs, making them resistant to coaching and preserving 
their psychometric utility (Schutte & Axelrod, 2013). In addition, EVIs are advantageous in that 
they directly assess the credibility of a specific response set rather than inferring it through 
scores on PVTs administered at different times throughout the assessment (Suhr & Gunstad, 
2000). 
 The mechanisms by which EVIs identify non-credible performance are versatile. The 
most common detection method relies on a demonstrated psychometric floor, beyond which a 
score is unlikely to occur (Greher & Wodushek, 2017). In other words, EVI failure may be 
construed as a deficit so severe that it is rarely observed in clinical populations, raising questions 
about its credibility (Babikian, Boone, Lu, & Arnold, 2006). Alternatively, EVIs may identify 
errors that are highly unusual even in cases of severe neurological dysfunction. An example of 
this is failure to maintain set (FMS) errors within the Wisconsin Card Sorting Task (Greve, 
Bianchini, Mathias, Houston, & Crouch, 2002; Lichtenstein, Erdodi, Rai, Mazur-Mosiewicz, & 
Flaro, 2016; Suhr & Boyer, 1999). Similarly, another type of EVI looks at atypical patterns 
across tests including performing better on more difficult tests compared to easier ones requiring 
the same basic skill. For example, an “atypical profile” occurs when an individual performs 
significantly better on a WAIS-R Vocabulary subtest compared to the Digit Span subtest 
(Mittenberg, Theroux-Fichera, Zielinski, & Heilbronner, 1995) or when a large discrepancy is 
observed in the age-corrected scaled score on the Coding and Symbol Search subtests, two 
analogous measures of psychomotor processing speed (Erdodi, Abeare, et al., 2017; Glassmire, 
Wood, Ta, Kinney, & Nitch, 2018).  
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 The strength of EVIs is also a source of liability in that they are closely linked to the 
cognitive function assessed by the test they are embedded within. Therefore, depending on the 
cutoff used, EVIs may be more prone to false-positives than free-standing tests (DeRight & 
Carone, 2015). One way to minimize the confound of cognitive ability on PVT outcome is to 
consider EVI’s across cognitive domains and/or aggregate multiple EVIs into a single validity 
composite (Erdodi, Nussbaum, et al. 2017).              
 Cutoffs. Cutoff scores separate non-credible performance and genuine dysfunction (Slick 
et al., 1999). A score on the passing side of the cutoff represents valid performance whereas a 
score on the failing side of the cutoff is interpreted as evidence of invalid performance (Bigler, 
2014). PVTs are optimized to minimize the rate of false positives (i.e., maximize specificity) at 
the expense of sensitivity. A generally accepted specificity rate is .90, resulting in a less than 
10% false positive rate (Larrabee, 2014b).  
Cutoff scores are determined a priori, based on previous literature, and allow clinicians 
to assess performance validity and estimate the likelihood that the profile is invalid. When 
applying cutoffs developed on a given clinical populations to a different diagnostic group it is 
important that clinicians reflect on the implications on classification accuracy. For example, an 
inflated false positive rate was reported when used on reliable digit span cutoffs in populations 
with severe memory disorders, cerebrovascular accidents, and children (Blaskewitz, Merten, & 
Kathmann, 2008; Schroeder, Twumasi-Ankrah, Baade, & Marshall, 2012).  Certain populations, 
such as dementia and intellectual disability, are exempt from PVTs due to the combination of 
well-established severe neurological impairment and high BRFail. Given the lack of universally 
applicable cutoffs, selecting a cutoff for a population that is yet to be validated carries the risk of 
diminished classification accuracy.  
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 Minimizing false positives. The use and interpretation of cutoff scores varies across 
settings, populations, and assessors. However, there is a consensus that PVTs should be 
optimized for specificity (i.e., to minimize false positive rates). Larrabee (2014b) identified six 
cognitive domains that should be assessed within a comprehensive clinical neuropsychology 
battery: (1) verbal symbolic abilities; (2) visuoperceptual and visualspatial judgement and 
problem solving; (3) sensorimotor function; (4) attention/working memory; (5) processing speed; 
(6) learning and memory-verbal and learning and memory-visual. While most free-standing 
PVTs are memory based, EVIs have been developed within each of the six domains. Larrabee 
(2014b) recommends completing assessments using neuropsychological batteries that include 
embedded measures from all 6 cognitive domains as well as free-standing PVTs. His sample 
battery contains a total of 27 tests, 10 of which include EVIs, and recommends additional free-
standing PVTs.  
 Careful consideration must be taken when deciding how many PVTs to use, how to 
minimize the burden of additional PVTs, and which cutoff scores are appropriate for each 
particular examinee (Rickards, Cranston, Touradji, & Bechtold, 2017). Although it is generally 
agreed that a single PVT failure provides insufficient evidence to determine non-credible 
performance, the exact number of PVT failures required to deem an entire neurocognitive profile 
invalid varies across assessors. It has been argued that false positive risk increases substantially 
with the number of PVTs given (Berthelson, Mulchan, Odland, Miller, & Mittenberg, 2013; 
Bilder, Sugar, & Hellemann, 2014), whereas many contend the risk of false positives can be 
reduced by responsibly adjusting cutoff scores or the number of PVT failures needed for the 
profile to be considered invalid (Larrabee, 2014a; Odland, Lammy, Martin, Grote, & Mittenberg, 
2015). Using multiple PVTs can increase sensitivity without reducing specificity because the 
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probability of having multiple PVT failures is low (Jasinski et al., 2011; Victor, Boone, Serpa, 
Buehler, & Ziegler, 2009). In fact, Larrabee (2014a) argued that multivariate models of 
performance validity assessment can protect against false positive errors. 
 A final consideration when determining the likelihood of invalid performance may be the 
level of failure. This is particularly true in a forced-choice paradigm. For example, if an 
individual answers 15% of the items correctly, a performance well-below chance level 
responding on the TOMM, the score can be confidently interpreted as non-credible (Slick & 
Sherman, 2012). Rickards, Cranston, Touradji, and Bechtold (2017) offered a systematic 
approach to PVT administration by creating a decision tree for neuropsychologists to follow 
when deciding whether or not to administer additional PVTs to determine credibility. The 
authors suggest that several factors should be considered when evaluating performance 
credibility including identification of risk groups (incentive, referral type, patient population), 
behavioural observations (non-credible symptom endorsement, inconsistencies in self-reports), 
and PVT and symptom validity outcomes.   
 In summary, in order to minimize the likelihood of a false positive error, 
neuropsychologists should utilize multiple independent tests (both embedded and free-standing) 
with high sensitivity and specificity that cover a variety of cognitive domains. Tests should be 
interpreted in the context of the overall evaluation and assessors should ensure that the PVT 
cutoffs used are appropriate for the population. To the best of our knowledge, no research has 
been conducted on PVT use in a population with HIV-associated neurocognitive disorders 
(HAND).   
HIV-Associated Neurocognitive Disorders 
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 HAND is cognitive dysfunction secondary to human immunodeficiency virus (HIV) 
infection. As many as 50% of HIV-positive (HIV+) individuals have neurocognitive impairment, 
which is associated with unemployment and reduced independence in daily living (Heaton, 
Marcotte, et al., 2004, 2010). Further, neurocognitive dysfunction in individuals with HIV 
increases mortality risk (Ellis et al., 1997).  
 Frascati criteria. In 1991, the American Academy of Neurology proposed the diagnosis 
of HAND be divided into two subtypes based upon the severity of cognitive and daily living 
impairments (Janssen et al., 1991). However, this subdivision was imprecise and insufficient as it 
did not specify criteria (i.e. the extent of impairment) nor did it allow for the diagnosis of 
patients with cognitive but not functional impairments. To address these shortcomings, the HIV 
Neurobehavioural Research Center proposed a new way to categorize the HAND diagnosis, now 
known as the Frascati criteria. This group identified three distinct categories: HIV-associated 
dementia (HAD), HIV-associated mild neurocognitive disorder (MND), and asymptomatic 
neurocognitive impairment (ANI; Antinori et al., 2007). To be classified into any of the three 
categories, differential diagnoses and comorbidities must be ruled out as the principal etiology 
for neurocognitive deficits. 
 HIV-associated dementia. Individuals with severe cognitive and functional impairments 
are diagnosed with HAD. To be placed in this category, patients must perform 2 standard 
deviations (SD) below the normative mean on two neurocognitive domains. They must also 
indicate moderate-to-severe levels of impairment in daily living, as assessed by self- or 
informant- reports, or be impaired on standardized measures of activities of daily living (Antinori 
et al., 2007). Although the number of HAND cases persists (Heaton et al., 2010), the incidence 
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of HAD has declined since the introduction of combination antiretroviral therapy (cART) to HIV 
treatment (Sacktor et al., 2002).  
 The cognitive impairment in HAD has been associated with reduced glutamate and 
glutamine levels within the frontal white matter, which may be indicative of neuronal 
dysfunction (Mohamed et al., 2010). Patients with HAD perform poorly on verbal fluency tasks, 
producing a greater number of errors and fewer total words than a non-demented HIV+ sample 
(Woods, 2004). On auditory learning and memory tests, words from the end of the list are 
overrepresented in HAD patients. This pronounced recency effect is commonly interpreted as an 
emergent sign of severe memory deficit, as the examinee is compensating for impaired encoding 
and consolidation skills by increasingly relying on auditory attention/echoic memory – cognitive 
domains that are relatively robust to the deleterious effects of neurodegenerative diseases (Scott 
et al., 2006).       
 Mild neurocognitive disorder. Individuals whose cognitive deficits lead to mild 
impairments in daily living are categorized as having MND. In order to meet the recommended 
criteria, a patient must score 1 SD below the normative mean in at least two cognitive domains. 
Mildly impaired daily living includes reports of diminished independence, accuracy, or 
efficiency in adaptive or occupational functioning, operationalized as a score 1 SD below 
normative means on standardized functional tests, and/or informant-/ self- reports of requiring 
assistance in 2 cognitive domains or activities (Antinori et al., 2007).       
 Asymptomatic neurocognitive impairment. The ANI classification allows for the 
objective diagnosis of patients presenting with cognitive dysfunction but no impairment in daily 
living. Similar to MND, the patient must score 1 SD below the normative mean in 2 cognitive 
domains but does not meet the remaining criteria of MND and HAD (Antinori et al., 2007). Over 
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half of those diagnosed with HAND only meet the criteria for ANI. This finding is consistent 
across geographic regions including Brazil (de Almeida et al., 2017), Korea (Ku et al., 2014), 
and China (Zhao et al., 2015).   
 Prognosis. The prognosis of HAND fluctuates over time and across cases. Over one year, 
only 58% of patients had stable cognitive performance, while the remaining 42% either 
worsened, improved, or oscillated between the two (Antinori et al., 2007). If a patient’s cognitive 
performance improves to the point that their HAND categorization is no longer appropriate, the 
specifier “in remission” may be added. cARTs appear to increase performance in several 
cognitive domains and improve prognosis up to 4 years after treatment initiation (Kore et al., 
2015; Robertson et al., 2012; Willen, Cuadra, Arheart, Post, & Govind, 2017).  
Ultimately, cognitive changes are difficult to predict and a patient’s neurocognitive 
ability should be continually monitored (Kamminga et al., 2017). Neurocognitive impairment has 
been associated with a variety of variables including lower cluster of differentiation 4 (CD4) 
counts, cART, cerebral spinal fluid HIV ribonucleic acid, smoking, neuropathy, substance use, 
stress, and body mass index (Akhtar-Khaleel et al., 2017; Chang, Lim, Lau, & Alicata, 2017; 
Cohen et al., 2011; Fellows et al., 2012; Gustafson et al., 2013; Keen & Turner, 2014; Kinuthia, 
Thigiti, & Gakinya, 2016; Kore et al., 2015; Muñoz-Moreno et al., 2008, 2013; Rubin et al., 
2015). Further, cytokine levels within the cerebral spinal fluid have been associated with slowed 
psychomotor speed and impaired executive functioning (Nolting et al., 2012). More specifically, 
high interleukin 6 levels have been linked to reduced processing speed abilities as demonstrated 
by impairments on the Symbol-Digit Modalities Test (SDMT) and Trail Making Test (TMT; 
Keen & Turner, 2014; Lake et al., 2015).  
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 Diagnosis. In order to categorize a HAND patient, a clinician must determine the 
presence and severity of their neurocognitive dysfunction. The 3 screening tools measuring 
neurocognitive deficits in HAND are traditional neuropsychological testing, the CogState 
computerized battery, and the demographically adjusted HIV dementia scale (HDS; Kamminga 
et al., 2017). However, only neuropsychological measures and the CogState battery have a 
sensitivity and specificity above .70 for detecting HAND (Cysique, Maruff, Darby, & Brew, 
2006; de Almeida et al., 2017; Moore et al., 2012). Further, the CogState battery has been 
developed as a research tool and has not been validated for clinical use. Therefore, the gold 
standard for cognitive testing in HAND research and clinical assessment is a neuropsychological 
battery (de Almeida et al., 2017; Kamminga et al., 2017).  
Some limitations of neuropsychological tests include their cost (clinician time, test 
material) and dependence on appropriate norms. When determining a patient’s relative standing 
compared to a strategically selected comparison group, it is important that relevant demographic 
variables known to influence test performance (age, education, and gender) are accounted for. 
Equally important are ethnic and racial background, with one study finding 71% of HIV+ 
African Americans were considered cognitively impaired when using the Caucasian norms, but 
this number was reduced 45% when using African American norms (Antinori et al., 2007). 
Similarly, once psychosocial and environmental factors were accounted for, group differences in 
executive functioning between HIV+ and HIV- children diminished (Llorente et al., 2014). 
Taken together, these studies emphasize the role of demographic factors in neuropsychological 
test outcomes and highlight the need of appropriate norms. 
 Neurocognitive testing. Antinori and colleagues (2007) outlined 7 domains of interest in 
neuropsychological testing, specifying that at least 5 domains should be examined prior to 
  
14 
HAND classification: attention, language, executive functioning, motor skills, memory/learning, 
processing speed, and sensory-perceptual abilities. The authors further specify that at least one of 
the deficits must be cognitive in nature, eliminating the diagnosis if deficits are only observed in 
sensory-perceptual and motor areas. There are a variety of tests that could be used to examine the 
six domains but some of the most common ones include the Hopkins Verbal Learning Test – 
Revised (HVLT-R), Grooved Pegboard Test (GPB), SDMT, TMT, Wisconsin Card Sorting Test 
(WCST), and verbal fluency measures (de Almeida et al., 2017; Eggers et al., 2017; Gomez, 
Power, Gill, & Fujiwara, 2017; Zhao et al., 2015). Following the introduction of cARTs to HIV 
treatment, the primary pattern of cognitive impairment shifted from reduced psychomotor and 
cognitive speed to impaired memory and executive functioning (Heaton et al., 2011). Still, 
impairments occur in all domains of interest within this population and should be assessed using 
a comprehensive battery of neuropsychological tests.           
 Within the HIV+ population, verbal learning and memory are commonly measured using 
the HVLT-R. Women with HIV have significantly reduced performance on total learning and 
delayed recall (Spies, Fennema-Notestine, Archibald, Cherner, & Seedat, 2012; Woods et al., 
2005). Interestingly, the HVLT-R has been identified as one of the most sensitive indicators of 
HAND and, as such, has been included in several brief screening batteries. When a two-test 
battery is used, the combination of HVLT-R total recall and non-dominant hand GPB T-score 
<40 had .78 sensitivity and .85 specificity (Carey et al., 2004). The combination of HVLT-R and 
the Stroop test T-score <40 on both or <35 on one of the tests had a sensitivity of .73 and a 
specificity of .83. (Moore et al., 2012).  
 The GPB is a measure of fine motor functioning and psychomotor speed. HIV-associated 
deficits in motor skills may relate to desynchronization between primary motor cortex and 
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supplementary motor areas (Wilson et al., 2013) and/or grey matter atrophy within the basal 
ganglia (Küper et al., 2011). 
 Within an HIV+ population, SDMT and the number-sequencing trial of the TMT (TMT-
A; D-KEFS Trails 2) is used to measure processing speed. HIV+ women perform worse on the 
SDMT total correct compared to HIV- controls even after education, age, ethnicity, and reading 
level are accounted for (Manly et al., 2011). In an HIV+ East Indian cohort, impaired 
performance on the TMT and SDMT was unaffected by illness duration during the early stages 
of the disease (Mandal et al., 2008). Impairments on these tests are not as severe in patients with 
intact immunological functioning and suppressed viral load, suggesting that low scores may be a 
consequence of the breakdown of immune systems in HIV (Cole et al., 2007). Interestingly, 
physical activity appears to protect against the deleterious effects of HIV on neuropsychological 
tests measuring attention (Monroe et al., 2017).  
 Executive functions in an HIV+ population is typically measured using the WCST and 
the letter-number sequencing trial on the TMT (TMT-B; D-KEFS Trails-4). Compared to HIV- 
controls, performance on both tests is impaired in HIV+ patients, with the greatest impairments 
seen in those with acquired immunodeficiency syndrome (AIDS; Basso & Bornstein, 2003; 
Moradi, Miraghaei, Parhon, Jabbari, & Jobson, 2012). Further, compared to demographically 
matched controls, individuals perinatally infected with HIV have lower D-KEFS Trails-4 
performance (Willen, Cuadra, Arheart, Post, & Govind, 2017). Performance on the TMT-B 
appears to decline much more rapidly over time in older adults with HIV than those without, 
suggesting that being HIV+ accelerates age-related cognitive decline (Sacktor et al., 2010). 
Executive functioning impairments on the WCST in an HIV+ sample have been correlated with a 
reduced caudate nucleus volume (Corrêa et al., 2016). 
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 Finally, letter and category fluency are commonly used to measure verbal abilities in an 
HIV+ samples (Cysique et al., 2011). HIV+ status does not appear to dramatically impair 
performance on verbal fluency tests (Thames et al., 2016). A meta-analysis of available literature 
found the effect size for impairments due to HIV are small and similar between letter and 
category fluency tests (Iudicello et al., 2008). Still, HIV is associated with psychometrically 
detectable word generation deficits (Iudicello et al., 2007, 2008). 
 Performance validity. As mentioned, neuropsychological test performance can be 
influenced by a variety of factors outside an examinee’s cognitive ability and several potential 
confounds may be present in an HIV+ population. Seventy-three percent of HIV+ patients have 
been classified as having a sleep disturbance according to the Pittsburgh Sleep Quality Index. 
Insomnia was particularly common among individuals with cognitive impairments (Rubinstein & 
Selwyn, 1998). The findings of a meta-analysis conducted in 2015 found that 58% of HIV+ 
patients had self-reported sleep disturbances. Across populations, North America had the greatest 
prevalence of sleep disturbances in this population, reaching over 70% (Wu, Wu, Lu, Guo, & Li, 
2015). The North American HIV+ population also has high levels of self-reported pain (Lawson 
et al., 2014). A systematic review of 61 studies found the prevalence of pain ranged between 
54% to 83% and was most commonly of moderate-to-severe intensity (Parker, Stein, & Jelsma, 
2014). The relationship of PVTs with sleep and pain within the literature is inconsistent. For 
example, in traumatic brain injury (TBI) sleep appears to have no effect on performance validity 
(Dean & Sterr, 2013). However, PVT outcome has been shown to correlate with sleep and pain 
in individuals with fibromyalgia (Johnson-Greene, Brooks, & Ference, 2013). Further, PVT 
BRFail was as high as 50% in individuals with chronic regional pain syndrome type 1 in litigative 
settings (Greiffenstein, Gervais, Baker, Artiola, & Smith, 2013). Further, individuals with HIV 
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also report symptom and emotional distress (Jaggers et al., 2014; Pereira, Fialho, & Canavarro, 
2014). Importantly, there is a high level of apathy in HIV+ patients (McIntosh, Rosselli, Uddin, 
& Antoni, 2015). Taken together, all of these comorbid symptoms associated with HIV may 
increase the likelihood of non-credible responding in HIV+ populations during 
neuropsychological testing.   
 Research aimed at understanding what the typical PVT profile looks like in an HIV+ 
population will facilitate the detection of non-credible response sets. Developing a psychometric 
method for differentiating valid and invalid profiles would allow clinicians and researchers to 
determine with greater confidence whether low scores on neuropsychological tests, and the 
corresponding HAND diagnosis, reflect true impairment or non-credible performance. As stated 
earlier, 42% of patients have changes in their neurocognitive performance over a 1-year time 
span (Antinori et al., 2007). Part of this may reflect fluctuations in performance validity. 
Therefore, research aimed at understanding performance validity in the HIV+ population has 
important psychometric implications that could improve diagnostic certainty and disease 
management.  
Objective 
 The overarching objective of this study is to assess performance validity in an HIV+ 
sample. To achieve this objective, archival HIV+ patient performance was compared to 
prospectively-collected undergraduate scores on EVIs contained within a HAND battery. To the 
best of our knowledge, the present study is the first to explore PVTs in an HIV+ sample. There 
were four groups within the HIV+ sample, those identified as neurocognitively normal (NN) and 
those diagnosed with ANI, MND, or HAD. EVI scores were compared between these four 
groups as well as to an undergraduate sample. Undergraduate participants were assigned to either 
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a control condition, where they were asked to try their best, or an experimental malingering 
condition (EXPMAL), where they were instructed to feign neurocognitive deficits. Therefore, a 
total of six groups existed within this study: NN, ANI, MND, HAD, controls, and EXPMAL.  
 In the first part of the study, we compared the BRFail across groups – both on individual 
measures and the cumulative failure rates (i.e., number of individuals who failed ≥1, ≥2, ≥ 3, ≥ 4, 
and ≥5 PVTs). We hypothesized that EXPMAL would have the highest BRFail as they are 
instructed to intentionally perform below their true ability. Additionally, we hypothesized that 
the level of EVI failure in EXPMAL would not differ from the HAD sample because dementia 
samples are prone to highly elevated BRFail on measures of performance validity (Davis, 2018). 
The next highest BRFail was expected in the MND and ANI samples. As certain EVIs have been 
shown to be sensitive to genuine cognitive impairments, this population was expected to have a 
higher BRFail than NN or controls. Lastly, we anticipated no BRFail difference between NN and 
controls. It is worth noting that these two groups were not matched for demographic variables. 
As with all undergraduate samples, we expected them to represent a unique set of demographic 
variables (young, educated, high functioning) difficult to generalize to the general population. 
However, because EVIs are believed to be insensitive to the majority of demographic variables, 
and it is assumed that both groups are performing to their true ability, no significant differences 
were anticipated. In summary, we hypothesized the following gradient of BRFail:  
EXPMAL = HAD > MND = ANI > NN = control 
 In order to develop a more thorough understanding of how invalid performance might 
impact scores on cognitive tests within HIV+ individuals, members of the MND, ANI, and NN 
groups were merged and then divided according to the total number of EVIs failed. The 
relationship between the number of EVIs failed and the examinee’s neuropsychological test 
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scores were then investigated. We hypothesized a strong negative linear relationship between 
number of EVI failures and performance on neuropsychological tests. 
 For the final part of our study, we examined the relationship between emotional 
functioning and performance validity. The MND, ANI, NN, and control group were merged and 
participants were regrouped according to their overall Patient Health Questionnaire (PHQ-9) 
scores. PHQ-9 scores were then compared to the number of EVIs failed to determine whether 
they may be a predictor of performance validity. It was hypothesized that those with higher 
PHQ-9 scores would have a greater number of EVI failures.      
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CHAPTER II 
Methods 
Participants 
 Sample 1: HIV+. The first sample was archival, using the data collected by Gomez, 
Power, Gill, and Fujiwara (2017). Their original research question asked whether risk-based 
decision making in an HIV+ sample correlated with a number of variables including 
neurocognitive performance. In the following section, a description of their cohort and 
methodology is provided. 
 Recruitment. All participants were diagnosed with HIV and recruited from the Southern 
Alberta Clinic (SAC) in Calgary, Alberta, Canada. Testing was completed between May 2013 
and January 2016. All participants had normal or corrected-to-normal vision and hearing. 
Further, they all had sufficient English fluency and were capable of providing informed consent. 
 Demographic variables. Gender, sexual orientation, current/nadir CD4 and T-cell count, 
current/peak plasma HIV viral load, psychiatric and medical comorbidities, duration of HIV 
infection, cART status, cART side effects and polypharmacy, and cART regimen central nervous 
system (CNS)-penetration effectiveness rank were collected via chart review. The participant’s 
age, ethnicity, country of origin, years of education, hepatitis C coinfection, and past/present 
substance use were collected via chart review and followed-up during the interview. Finally, 
cART adherence within the previous 5 days as well as perceived health and daily functioning 
were assessed during the interview.   
 HAND diagnosis. The “Frascati criteria” were used to determine HAND status. 
Diagnoses were further verified using the participant’s medical record. HAND status could not 
be obtained if the participant had a history of head trauma with loss of consciousness exceeding 
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5 minutes, severe psychiatric or neurological disorders, or opportunistic CNS infection. At the 
time of testing, the participants spoke English fluently, and had greater than 9 years of education.  
 Number of participants. A total of 291 participants were enrolled in the study, 64 with 
neurocognitive impairments classified as HAND (25 ANI, 31 MNI, 8 HAD) and 227 NN.  
 Ethics approval. Data set collection was approved by the University of Calgary Conjoint 
Health Research Ethics Board (ethics ID: REB13-0615_REN2). All participants consented for 
their data to be used for research purposes. Ethical approval was also received from the 
University of Windsor Research Ethics Board.      
 Sample 2: Undergraduates. The second group of participants were prospectively 
collected undergraduates. The student sample provided control and EXPMAL groups.  
 Recruitment. Undergraduate students were recruited from the University of Windsor 
Psychology Participant Pool. One screening question was asked prior to viewing the recruitment 
posting: “Are you 18 years of age or older?”. If the answer was YES, the student was able to 
view the recruitment posting. The recruitment posting asked that participants identify as HIV- 
prior to signing up for the study. An email reminder was sent to students signed up for the study 
48 hours prior to testing and a 24-hour cancellation notice was set. In order to optimize testing 
conditions, participants were asked to bring their glasses/contacts and/or hearing aid to the 
appointment. The battery took approximately 120 minutes to complete and participants received 
2.5 credits for their involvement.    
 Inclusion criteria. All participants were 18 years of age or older and reported that they 
were HIV-.  
 Number of participants. A total of 74 undergraduate participants were recruited for the 
study. Two students were assigned to the control condition for each student assigned to EXPMAL 
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(2 controls: 1 EXPMAL). Only controls were included within the majority of our hypotheses, thus 
we wanted to maximize the sample size of this condition. Further, the 2:1 ratio was identified by 
G*Power as sufficient to observe group differences if they exist (Faul, Erdfelder, Lang, & 
Buchner, 2007). In total, fifty-one participants were randomly assigned to the control condition, 
while the remaining 23 were assigned to EXPMAL.    
Measures 
 Gomez, Gill, Power, and Fujiwara (2017). All testing was completed in a quiet, 
distraction-free room located in the SAC. After giving informed consent, neuropsychological 
testing followed a brief interview. All testing was completed by a trained researcher at the clinic.  
 HAND battery. The format of the HIV+ neurocognitive assessment was as follows: brief 
interview, D-KEFS verbal fluency (FAS/animals/boys names), Wide Range Achievement Test 4 
(WRAT-4) Reading, Game of Dice, HVLT-R (learning trials 1-3, recognition trial), SDMT, 
WCST (64 cards), D-KEFS Trails 2 and 4, GPB (dominant hand, non-dominant hand), PHQ-9, 
HVLT-R (delayed recall).   
 Prospective undergraduate sample. The measures and procedures selected to be used in 
the undergraduate sample aimed to replicate the Gomez, Gill, Power, and Fujiwara (2017) study 
as closely as possible. However, the Game of Dice was removed as it adds to administration 
time, is an experimental measure without statistical norms, and is not involved in our research 
questions. One free-standing PVTs (WCT) was added to the battery to improve the classification 
accuracy of undergraduate participant profiles as valid or invalid (Iverson, Franzen, & 
McCracken, 1994). 
 Test administration. Testing was completed in a quiet, distraction-free room in the 
University of Windsor. Informed consent was obtained from all participants prior to 
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psychometric testing. Participants completed a brief questionnaire in order to obtain basic 
demographic information. Neuropsychological testing followed. All participants were fully 
debriefed following testing. The test sequence was as follows: brief interview, WCT 
(counterbalanced; either at the beginning or end of battery), WRAT-4 Reading, D-KEFS verbal 
fluency (FAS/animals/boys names), HVLT-R (learning trials 1-3), SDMT, D-KEFS Trails 2 and 
4, GPB (dominant hand, non-dominant hand), HVLT-R (delayed recall, recognition), PHQ-9, 
and WCT (counterbalanced; either at the beginning or end of battery).  
    Demographic variables. Basic demographic information was collected during the 
questionnaire (e.g. gender, age, handedness, and years of education). Psychiatric and 
neurological histories were also collected (Appendix A). 
 Experimental malingering & control conditions. Undergraduates were randomly 
assigned into one of two conditions: EXPMAL or control. Following the brief interview, 
participants were given a sealed envelope containing instructions on how to perform for the 
remainder of the experiment. Envelopes were quasi-counterbalanced to ensure random group 
selection. The envelope was used to prevent the researcher conducting the experiment from 
knowing the participant’s condition and potentially biasing results. The instructions to controls 
requested they put forth their best effort while completing all tests. In contrast, participants in the 
EXPMAL condition received detailed instructions on how to feign cognitive deficits in a pattern 
similar to that following a moderate to severe TBI. The given scenario has been previously used 
within our lab and was modelled after scenarios developed by DenBoer & Hall (2007) and Suhr 
& Gunstad (2000; Appendix B). The recommendations for simulation studies provided by 
Rogers (2008) were adhered to. Following the end of testing, a manipulation check was 
completed (Appendix C).     
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 WRAT-4. Similar to the original study, participants completed the WRAT-4 Reading 
subtest. The WRAT-4 Reading subtest (blue version) is a list of 55 words, ordered according to 
difficulty, which the participant must read aloud. Pronunciation was scored as correct or 
incorrect (Wilkinson & Robertson, 2006). 
 PHQ-9. The PHQ-9 is a brief questionnaire measuring self-reported depressive 
symptoms over the past two weeks (Kroenke, Spitzer, & Williams, 2001). 
 Performance validity tests. D-KEFS verbal fluency, D-KEFS Trails, WCST, GPB, and 
HVLT-R all contain EVIs. Therefore, a total of 8 EVIs included within the original HAND 
battery were analyzed and tested in undergraduates (Table 1). The EVIs span a variety of 
cognitive domains and include both verbal and non-verbal measures. Conservative and liberal 
cutoff scores were chosen for each test to optimize specificity or sensitivity, respectively. 
Conservative cutoff scores aimed to have  .90 specificity whereas liberal cutoff scores had 
improved sensitivity at the expense of slightly reduced specificity ( .84) (Boone, 2013; 
Larrabee, 2003). 
Table 1 
Neurocognitive Testing Battery 
Name Abbreviation EVI Reference 
Letter Fluency FAS Yes Delis, Kaplan, & Kramer, 2001 
Category Fluency Animals Yes Delis, Kaplan, & Kramer, 2001 
WRAT-4 Reading WRAT-4 Reading No Wilkinson & Robertson, 2006 
HVLT-R HVLT-R Yes Brandt & Benedict, 2001 
Symbol Digit 
Modalities Test 
SDMT No Smith. 1973 
WCST 64 Card 
Version 
WCST-64 Yes Kongs, Thompson, Iverson, & 
Heaton, 2000 D-KEFS Trail  T2 & T4 Yes D lis, Kaplan, & Kramer, 2001 
Grooved Pegboard GPB Yes Trites, 1977 
PHQ-9 PHQ-9 No Kroenke, Spitzer, & Williams, 2001 
 
 D-KEFS letter fluency. Participants were instructed to generate as many words as they 
could think of beginning with a specific letter (F, A, and S ) in 60 seconds following some basic 
rules (cannot use proper names, numbers or the same word with different suffix; Delis, Kaplan, 
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& Kramer, 2001). Many of the EVIs within FAS are typically based on demographically 
adjusted T-scores (Curtis, Thompson, Greve, & Bianchini, 2008; Sugarman & Axelrod, 2015), 
which differ from age corrected scaled scores (ACSS) in the D-KEFS norms. Thus, raw scores 
were converted to T-scores using demographically adjusted norms by Heaton, Miller, Taylor, & 
Grant (2004). DelisSugarman and Axelrod (2015) found that an FAS T-score of ≤ 31 produced 
.90 specificity and .30 sensitivity, while an animal cutoff of T ≤ 33 had a .91 specificity and .42 
sensitivity. Similarly, Curtis, Thompson, Greve, & Biachini (2008) suggested cutoff scores of ≤ 
31 (.95 specificity, .27 sensitivity) and ≤33 (.90 specificity, .36 sensitivity) on FAS.   
 D-KEFS category fluency. Following the same structure as letter fluency, category 
fluency required the participant to list as many animals and boys names as they can within 60 
seconds (Delis et al., 2001). Sugarman and Axelrod (2015) suggested a conservative raw score 
cutoff of ≤12 (sensitivity: .50; specificity: .90) and a liberal raw score cutoff of ≤ 13 (sensitivity: 
.55; specificity: .84) on animal fluency. The combined total of both categories was converted to 
an ACSS and used as a measure of cognitive ability. 
 HVLT-R. This is a test of auditory verbal learning and memory. Participants listened to a 
list of 12 words and were asked to recall as many as they could after each trial. For the purposes 
of our testing, three acquisition trials and a Yes/No recognition trial were administered (Brandt 
& Benedict, 2001). One study has published EVI cutoffs for the discrimination trial. They found 
correct responding during the discrimination trial  5 has a sensitivity of .93 but a specificity of 
.53, while the number of correct responses being  6 has a sensitivity of .74 and specificity of .84 
(Sawyer, Testa, & Dux, 2017). 
 WCST. This test is a measure of concept formation and cognitive flexibility. Participants 
were asked to match each card, handed one at a time, to one of four key cards. Each card 
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contains 3 salient features (colour, form, number; Kongs, Thompson, Iverson, & Heaton, 2000). 
In the full 128 card version, FMS and the number of categories completed were included into a 
logistic regression equation that successfully differentiated credible from non-credible 
performance (Suhr & Boyer, 1999). FMS on the WCST is relatively insensitive to TBI and 
executive deficits in both adults (Heaton, Chelune, Talley, Kay, & Curtis, 1993; Jodzio & 
Biechowska, 2010) and children (Lichtenstein, Erdodi, Rai, Mazur-Mosiewicz, & Flaro, 2016). 
In contrast to healthy undergraduates and those with credible TBI, experimental malingerers and 
patients with TBI seeking compensation had more than double the number of FMS errors (≥ 2; 
King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Suhr & Boyer, 1999). Larrabee (2003) 
reported .87 specificity and .48 sensitivity for FMS errors ≥ 2. Across a variety of non-litigating 
clinical populations, the mean FMS was consistently <1. However, FMS as an EVI has been 
calibrated using the 128-card version but the current study used the 64-card version. As such, the 
theoretical probability of FMS errors is lower (half). Therefore, at conventional cutoffs, the FMS 
in the 64-card version is expected to have higher specificity.  
 D-KEFS Trails 2 and 4. When completing Trail 2, examinees were instructed to connect 
circles containing numbers in increasing order using a pencil. Trail 4 requires letter-number 
sequencing: when connecting letters to numbers, examinees are asked to alternate between 
numbers in increasing and letters in alphabetical order. Trail 2 measures processing speed and 
simple visual attention. Trail 4 measures cognitive flexibility and divided attention (Delis et al., 
2001). Although the original Trail Making Test has been validated as a PVT (Busse & 
Whiteside, 2012; Iverson, Lange, Green, & Franzen, 2002; Ruffolo, Guilmette, & Willis, 2000; 
Shura, Miskey, Rowland, Yoash-Gantz, & Denning, 2016), there has been no research exploring 
the utility of D-KEFS TMT in detecting non-credible performance. Our research group recently 
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investigated the potential of D-KEFS Trails to function as EVIs (Erdodi, Hurtubise, et al., 2018). 
We found that a Trails 2 ACSS cutoff of 5 met minimum specificity standards (.85 - .88) with a 
sensitivity of .43-.57. At the more conservative cutoff of  3, specificity improved (.87-.93) at 
the expense of sensitivity (.26-.38). On Trails 4, cutoffs of  4 (specificity: .88, sensitivity: .45-
.57) and  1 (specificity: .90-.93, sensitivity: .27-.48) produced good combinations of specificity 
and sensitivity.    
 Grooved Pegboard. This test is a measure of fine motor speed and requires participants to 
rotate pegs into peg holes using their dominant and, later, their non-dominant hand. Speed and 
the number of pegs dropped were recorded (Trites, 1977). A dominant hand T-score cutoff  29 
produced a sensitivity of .61 and a specificity of .90 when groups were classified according to 
performance on the words subtest of the Warrington’s Recognition Memory Test and two other 
composite measures of performance validity. In contrast, a dominant hand T-score cutoff of  25 
had a sensitivity of .52 and a specificity of .96. The same cutoffs produced good combinations of 
sensitivity and specificity for the non-dominant hand (liberal: .65 and.89; conservative: .50 and 
.96; Erdodi, Seke, et al., 2017).  
 Statistical Analysis 
 All statistical procedures were performed using Statistical Package for the Social 
Sciences (SPSS) version 22.0. Descriptive statistics (mean, SD, range, skew, kurtosis) for 
demographic variables were reported in all four groups. These variables were compared using a 
t-test for continuous variables (e.g. age, education) and a chi-square test of independence for 
categorical variables (e.g. gender). For all hypotheses, BRFail across groups was compared at 
liberal and conservative cutoffs separately.  
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 Hypothesis 1: EVI failure will vary according to group membership (EXPMAL= 
HAD  > MND = ANI > NN = CON). It was expected that this prediction would remain true 
regardless of whether the dependent variable was the total number of EVIs failed (continuous) or 
BRFail (categorical: Pass/Fail). For each EVI, participants were scored as either passing or failing 
according to the predetermined cutoff. Each participant received a total score of the number of 
EVIs they failed. As this was a continuous variable with a maximum score of 8, a between-
subjects analysis of variance (ANOVA) was conducted and a comparison was made between the 
six groups. Assumptions checked included normality, equal variance, and independence of 
groups. Post-hoc contrasts were uncorrected post-hoc tests. An effect size estimate (Cohen’s d) 
was computed for significant contrasts. 
 BRFail was compared between the six groups by looking at whether groups varied in the 
number of individuals failing 1, 2, and ≥3 EVIs at the liberal cutoffs and 2, 3, and ≥4 EVIs at 
the conservative cutoffs.  These analyses were done to compare proportions between groups. To 
allow for easier clinical interpretation, risk ratios were computed, followed by 2 analysis to 
determine statistical significance.     
 Hypothesis 2: Those failing a greater number of EVIs will perform more poorly on 
neuropsychological tests. To test this hypothesis, the MND, ANI and, NN groups were merged 
together and this large pool was divided according to the number of EVIs each participant failed. 
All neurocognitive measures that doubled as EVIs were removed from this analysis to reduce the 
effects of collinearity. For the purpose of our analysis, the independent variable had 3 levels at 
the liberal cutoffs: 2 EVIs failed, 3 EVI failed, and 4 EVIs failed and 3 levels at the 
conservative cutoffs: 1 EVIs failed, 2 EVI failed, and 3 EVIs failed. ANOVAs were 
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conducted to compare the performance across these three groups on six measures of cognitive 
ability.  
 Hypothesis 3: Regardless of HIV status, individuals who have elevated PHQ-9 
scores will fail more EVIs than those who do not. Using their PHQ-9 scores, all participants 
except the EXPMAL and HAD groups were divided into none (0), minimal (1-4), mild (5-9), 
moderate (10-14), moderately severe (15-19), and severe ( 19) depression. In a manner similar 
to Hypothesis 1, BRFail was conducted for 2, 3, and ≥4 EVIs at the liberal cutoffs and 1, 2, and 
≥3 EVIs at the conservative cutoffs using a 2 analysis. Additionally, the total number of failed 
EVIs between participants was calculated and compared between the six groups (none, minimal, 
mild, moderate, moderately severe, and severe). As there were six groups to compare, an 
ANOVA was conducted. An additional ANOVA was conducted assessing the relationship 
between EVI failure and depressive symptom severity as indicated by question 10 on the PHQ-9 
(not very difficult, somewhat difficult, very difficult, and extremely difficult). 
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CHAPTER III 
Results 
Data Cleaning 
 Prior to data analysis, all relevant variables were scanned using descriptive statistics to 
identify human error in data scoring or entry. All data were deemed acceptable. Within the HIV+ 
dataset, no cases were removed. A total of 9 cases were removed from the student dataset and 
subsequent analysis. Of these, 2 were removed due to inadequate demographic information that 
prevented comparison of their performance to age-matched controls. One participant in the 
EXPMAL group reported “not pretending” to have a head injury or following instructions. 
Additionally, 6 participants were excluded from subsequent analysis because they did not 
complete all 8 EVIs. The final sample size was 346 participants.  
Testing of Assumptions 
 Skewness and Kurtosis. T-tests and ANOVAs assume that data are normally distributed.  
In order to test for the normal distribution of data, skewness and kurtosis values were assessed 
for all continuous variables (e.g. FAS T-Score, Animals T-Score, Verbal Fluency Boys Names, 
HVLT-R Total Learning, HVLT-R Delayed Recall, WCST Categories Completed, D-KEFS 
Trails 2 and 4, GPB Dominant and Non-Dominant Hand, and PHQ-9 Total Score). None of the 
variables produced skewness or kurtosis values outside the acceptable range of +2 and -2 (Pituch 
& Stevens, 2016).  
 Equality of Variance. Equal variance across populations was tested using the Levene’s 
Test of Equality of Variances for each variable and is reported below. 
 Independence of Observations. The only assumption of 2 test of independence is the 
independence of observations. All groups contain greater than 5 cases and participants were 
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placed into a single group. Further, it is not believed that the group membership of one 
participant influenced the group membership of another.  
Main Analyses 
 Demographic Variables. T-tests were conducted to determine whether demographic 
differences exist between HIV+ and student participants. Overall, the undergraduate sample was 
younger (Mstudent = 22.1, SDstudent = 5.0) than the HIV+ sample (MHIV+ = 47.4, SDHIV+ = 10.9; 
t(354) = 28.45, p < .001, d = 2.98).  The student sample had completed more years of education 
(Mstudent = 14.6, SDstudent = 1.1) than those in the HIV+ dataset (MHIV+ = 14.1, SDHIV+ = 2.5; 
t(354) = -2.42, p = .016, d = 0.26).  
 Sample differences in handedness and gender were assessed using 2 tests of 
independence. Handedness did not differ between the two samples (2 = 3.51, p = .173). The 
proportion of female and male participants varied between samples (2 = 158.6, p < .001), with a 
greater proportion of female participants in the student (86.2%) than HIV+ (11.3%) sample.  
 Validating EVIs in the HAND Battery using a student sample. A total of eight 
established EVIs were included within the HAND battery. Predetermined cutoffs, outlined in the 
methods section, did not provide adequate sensitivity and specificity for the undergraduate 
sample. Therefore, an exploratory analysis was conducted. Beginning with the proposed cutoffs, 
the sensitivity and specificity of alternative cutoffs were also computed. The liberal and 
conservative cutoffs used for hypothesis testing were those producing specificity nearest to .84 
and .90 respectively (Table 2). Two criterion measures were used to determine sensitivity and 
specificity: (1) EXPMAL vs. Controls and (2) WCT raw scores > 47 (pass) vs.  47 (Fail; Erdodi, 
Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; Pearson, 2009).  
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Table 2  
Liberal and Conservative Cutoffs for each EVI as determined by sensitivity and specificity of 
each EVI against criterion PVT in the sample 
EVI Scale Liberal Conservative 
HVLT-R RD Raw score ≥ 8 ≥ 7 
WCST FMS Raw score ≤ 2 ≤ 1 
D-KEFS Trail 2  ACSS ≥ 6 ≥ 5 
D-KEFS Trail 4 ACSS ≥ 7 ≥ 6 
GPB DOM T-score ≥ 31 ≥ 29 
GPB ND T-score ≥ 33 ≥ 31 
FAS  T-score ≥ 33 ≥ 31 
Animals  T-score ≥ 33 ≥ 29 
Note. EVI: Embedded Validity Indicator; HVLT-R RD: Hopkins Verbal Learning Test – revised recognition 
discrimination (Sawyer, Testa, & Dux, 2017); WCST FMS: Wisconsin Card Sorting Test failure to maintain set 
(King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999). D-KEFS T2 & T4: 
Delis-Kaplan Executive Functioning System, Trails 2 and 4 (Erdodi, Hurtubise, et al., 2018); GPB DOM: Grooved 
Pegboard Test dominant hand (Erdodi, Seke, et al., 2017); GPB ND: Grooved Pegboard Test non-dominant hand 
(Erdodi, Seke, et al., 2017); FAS & Animals: Delis-Kaplan executive functioning system (Curtis, Thompson, Greve, 
& Biachini, 2008; Sugarman & Axelrod, 2015). 
 
 Area under the curve (AUC) provides an objective measure of overall classification 
accuracy (i.e. determining whether a profile is valid or invalid). AUC may be classified as 
acceptable (.70-.79), excellent (.80-.89), or outstanding (≥ .90; Hosmer & Lemeshow, 2000). 
With the exception of WCST FMS, all EVIs fell within or above the acceptable range (Table 3). 
WCST FMS AUC values fell well below the acceptable level (.64) but within the acceptable 
range (.75) when using the EXPMAL criterion and WCT as the PVT criterion, respectively. D-
KEFS T2, FAS, and Animals produced acceptable classification accuracy. HVLT-R RD and 
GPB Dom had excellent classification accuracy. EVI classification varied depending on the 
criterion measure used for D-KEFS T4 and GPB ND. D-KEFS T4 AUC acceptable classification 
accuracy using the WCT and excellent classification accuracy when EXPMAL was the criterion 
PVT. In contrast, excellent classification accuracy was observed with GPB ND using EXPMAL 
criterion but outstanding accuracy with WCT as the criterion.  
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Table 3 
Area Under the Curve and Confidence Intervals of Select EVI Validity Cutoffs against Various 
Criterion PVTs 
  Criterion PVT 
 EXPMAL  WCT 
         
      EVI 
 
AUC 95% CI  AUC 95% CI 
HVLT-R RD .81 .69-.93  .88 .76-1.00 
WCST FMS .64 .48-.80  .75 .58-.91 
D-KEFS T2 .79 .65-.92  .73 .58-.88 
D-KEFS T4 .83 .72-.95  .75 .61-.89 
GPB Dom .82 .70-.94  .84 .73-.96 
GPB ND .80 .67-.92  .92 .83-1.00 
FAS .71 .57-.85  .70 .56-.84 
Animals .76 .63-.89  .76 .60-.92 
 
Note. EVI: Embedded Validity Indicator; AUC: Area under the curve; 95% CI: 95% confidence interval; WCT: 
Word Choice Test (Pass: WCT score > 47; Fail: WCT score 47 (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & 
Medoff, 2014; Pearson, 2009); HVLT-R RD: Hopkins Verbal Learning Test – Revised recognition discrimination 
(Sawyer, Testa, & Dux, 2017); WCST FMS: Wisconsin Card Sorting Test failure to maintain set (King, Sweet, 
Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999). D-KEFS T2 & T4: Delis-Kaplan 
Executive Functioning System, Trails 2 and 4 (Erdodi, Hurtubise, et al., 2018); GPB DOM: Grooved Pegboard Test 
dominant hand (Erdodi, Seke, et al., 2017); GPB ND: Grooved pegboard non-dominant hand (Erdodi, Seke, et al., 
2017); FAS: Letter fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);  
Animals: Category fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
 
  Table 4 presents the sensitivity and specificity for the liberal and conservative cutoffs of 
EVIs within the HAND battery. The classification accuracy for published cutoffs on seven of the 
eight EVIs within the HAND battery hovered around the Larrabee limit: .50 sensitivity at .90 
specificity (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014) against EXPMAL and 
WCT as criterion measures. Specificity values were generally lower against the WCT than 
EXPMAL. This pattern of findings is likely an artifact of differences in the BRFail (21.9% vs. 
32.3%). Overall, classification accuracy was similar across cutoffs between the two criterion 
measures.    
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Table 4 
BRFail , Sensitivity and Specificity of Select EVI Validity Cutoffs against Various Criterion PVTs 
   Criterion PVTs 
   EXPMAL  WCT 
   SENS SPEC  SENS SPEC 
EVI Cutoff BRFail 32.3  21.9 
HVLT-R RD ≤8 17.2 .42 .96  .64 .96 
 ≤7 14.1 .38 .98  .57 .98 
WCST FMS ≥1 26.6 .43 .82  .64 .84 
 ≥2 9.4 .24 .98  .29 .96 
D-KEFS T2 ≤6 26.6 .57 .89  .43 .78 
 ≤5 14.1 .29 .93  .28 .90 
D-KEFS T4 ≥7 32.8 .67 .84  .50 .72 
 ≥6 26.6 .67 .93  .50 .80 
GPB Dom ≤31 31.3 .67 .86  .64 .78 
 ≤29 23.4 .57 .93  .64 .88 
GPB ND ≤33 29.7 .62 .86  .93 .88 
 ≤31 23.4 .52 .91  .78 .92 
FAS ≤33 23.4 .43 .86  .36 .80 
 ≤31 18.8 .43 .93  .36 .86 
Animals ≤33 20.3 .43 .91  .57 .91 
 ≤29 14.1 .33 .95  .43 .94 
 
Note. EVI: Embedded validity indicator; BRFail : Base rate of failure (% of the sample that failed a given cutoff); 
WCT: Word Choice Test (Pass: WCT score > 47; Fail: WCT score 47 (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, 
& Medoff, 2014; Pearson, 2009); HVLT-R RD: Hopkins Verbal Learning Test – Revised recognition discrimination 
raw score (Sawyer, Testa, & Dux, 2017); WCST FMS: Wisconsin Card Sorting Test failure to maintain set raw 
score (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999). D-KEFS T2 & T4: 
Delis-Kaplan Executive Functioning System, Trails 2 and 4 age-corrected scaled score (Erdodi, Hurtubise, et al., 
2018); GPB DOM: Grooved Pegboard Test dominant hand demographically adjusted T-score (Erdodi, Seke, et al., 
2017); GPB ND: Grooved Pegboard Test non-dominant hand demographically adjusted T-score (Erdodi, Seke, et 
al., 2017); FAS: Letter Fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);  
Animals: Category Fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015) 
 
 To further quantify the utility of each EVI, t-tests were conducted to compare 
performance for each criterion PVT (Table 5). Significant differences were observed between 
controls and EXPMAL as well as between Pass and Fail of the WCT. Standard interpretation of 
Cohen’s d suggests scores greater than .2 as small, greater than .5 as moderate, and greater than 
.8 as large effect sizes. Only WCST FMS had an effect size in the small range (d = .28). The 
remaining tests had moderate to large effects.   
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Table 5 
The Effect of Invalid Performance on Various EVIs in the Student Sample 
 Criterion PVTs  
 Experimental Malingering  WCT  
EVI IV M SD t p d  WCT M SD t p d  
HVLT-R RD NC 10.8 1.3 3.80 .001 1.12 † Pass 10.8 1.3 4.26 .001 1.60 † 
 EM 7.1 4.5     Fail 5.4 4.6     
               
WCST FMS NC .2 .5 -2.34 .028 .28 † Pass .2 .7 -2.7 .014 .98 † 
 EM .9 1.2     Fail 1.1 1.1     
               
D-KEFS T2 NC 9.8 2.7 4.47 <.001 1.10  Pass 9.2 3.2 2.89 .005 .84  
 EM 6.1 3.9     Fail 6.2 3.9     
               
D-KEFS T4 NC 9.5 2.2 4.88 <.001 1.40 † Pass 8.8 2.9 2.79 .012 .87 † 
 EM 5.5 3.4     Fail 5.9 3.7     
               
GPB Dom NC 44.5 11.2 4.78 <.001 1.24  Pass 43.3 12.2 4.50 <.001 1.41  
 EM 29.9 12.3     Fail 27.2 10.5     
               
GPB ND NC 43.5 9.0 4.26 <.001 1.08  Pass 43.4 9.3 5.88 <.001 1.86  
 EM 32.3 11.6     Fail 27.2 8.1     
               
FAS NC 42.1 9.9 2.74 .008 .72  Pass 41.3 11.0 2.19 .032 .74  
 EM 34.8 10.3     Fail 34.4 7.4     
               
Animals NC 44.5 11.2 3.79 <.001 1.24  Pass 44.0 9.4 3.69 <.001 1.03  
 EM 29.9 12.3     Fail 32.9 12.0     
 
Note. EVI: Embedded validity indicator; NC: Normal controls; EM: Experimental malingerer; WCT: Word Choice 
Test (Pass: WCT score > 47; Fail: WCT score 47 (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; 
Pearson, 2009)); HVLT-R RD: Hopkins Verbal Learning Test – Revised recognition discrimination (Sawyer, Testa, 
& Dux, 2017); WCST FMS: Wisconsin Card Sorting Test failure to maintain set (King, Sweet, Sherer, Curtiss, & 
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999). D-KEFS T2 & T4: Delis-Kaplan Executive Functioning 
System, Trails 2 and 4 (Erdodi, Hurtubise, et al., 2018); GPB DOM: Grooved Pegboard Test dominant hand 
(Erdodi, Seke, et al., 2017); GPB ND: Grooved Pegboard Test non-dominant hand (Erdodi,Seke et al., 2017); FAS: 
Letter fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015);  Animals: 
Category fluency T-score (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
 †: Levene’s test of homogeneity of variance significant at p-value <.05 
 
 
 Although it is useful to understand each EVI individually, cumulative EVI failure\e is 
more clinically relevant. For this reason, AUC and 95% confidence intervals were also 
calculated by summing the total number of EVIs failed at liberal and conservative cutoffs (Table 
6). Regardless of criterion PVT, liberal cutoffs produced excellent classification accuracy (.88-
.89). Although WCT AUC suggested acceptable classification accuracy using conservative 
cutoffs (.78), the EXPMAL criterion suggested that it is outstanding (.92).   
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Table 6 
AUC and 95% CI of Select Levels of Failure against Various Criterion PVTs 
  Criterion PVT  
 EXPMAL  WCT  
Number of EVI Failures AUC 95% CI  AUC 95% CI  
Liberal .89 .79-.98  .88 .80-.98  
Conservative .92 .84-.99  .78 .76-.99  
Note: EXPMAL: Experimental malingering condition; WCT: Word Choice Test (Pass: WCT score > 47; Fail: WCT 
score 47 (Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; Pearson, 2009)); AUC: Area under the 
curve; Liberal: EVIs failed at the liberal cutoff (Hopkins Verbal Learning Test – Revised recognition discrimination 
(HVLT-R RD) ≤ 8; Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 2; Delis-Kaplan Executive 
Functioning System (D-KEFS) Trail 2 ≤ 6; D-KEFS Trail 4 ≤ 7; Grooved Pegboard Test (GPB) dominant hand ≤ 
31; GPB non-dominant hand ≤ 33; FAS ≤ 33; Animals ≤ 33); Conservative: EVIs failed at the conservative cutoff 
(HVLT-R RD ≤ 7; WCST FMS ≥ 1; D-KEFS Trail 2 ≤ 5; D-KEFS Trail 4 ≤ 6; GPB dominant hand ≤ 29; GPB non-
dominant hand ≤ 31; FAS ≤ 31; Animals ≤ 29). 
 
 BRFail, specificity, and sensitivity were calculated using cumulative failure cutoffs for 
liberal and conservative EVIs (Table 7). As the number of EVIs failed increased, cutoffs 
produced greater specificity at the expense of sensitivity. At the liberal and conservative cutoffs 
of  ≥4 and ≥3, respectively, sensitivity and specificity approached the Larrabee limit (Erdodi, 
Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014). Again, specificity values were greater 
when using EXPMAL as the criterion PVT rather than WCT. 
  
  
37 
Table 7 
Sensitivity and Specificity of the Cumulative EVI Failures at Select Cutoffs against Various 
Criterion PVTs 
   Criterion PVT 
   EXPMAL  WCT 
  BRFail 32.3  21.9 
Level of Cutoff Number Failures  SENS SPEC  SENS SPEC 
Liberal ≥1 67.7 .95 .46  1.00 .40 
 ≥2 47.7 .86 .71  .93 .64 
 ≥3 30.8 .81 .76  .79 .82 
 ≥4 23.1 .57 .93  .64 .88 
 ≥5 13.8 .43 1.00  .50 .96 
Conservative ≥1 47.7 .95 .75  .93 .64 
 ≥2 32.3 .91 .81  .80 .79 
 ≥3 23.1 .57 .93  .71 .90 
 ≥4 18.5 .48 .96  .57 .92 
 ≥5 9.2 .29 1.00  .36 .98 
Note: Embedded validity indicator; BRFail : Base rate of failure (% of the sample that failed a given cutoff); EXPMAL: 
Experimental malingering condition; WCT: Word Choice Test (Pass: WCT score > 47; Fail: WCT score 47 
(Erdodi, Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; Pearson, 2009); Liberal cutoffs (Hopkins Verbal 
Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 8; Wisconsin Card Sorting Test failure to 
maintain set (WCST FMS) ≥ 2; Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 6; D-KEFS Trail 4 
≤ 7; Grooved Pegboard Test (GPB) dominant hand ≤ 31; GPB non-dominant hand ≤ 33; FAS ≤ 33; Animals ≤ 33); 
Conservative cutoffs (HVLT-R RD ≤ 7; WCST FMS ≥ 1; D-KEFS Trail 2 ≤ 5; D-KEFS Trail 4 ≤ 6; GPB dominant 
hand ≤ 29; GPB non-dominant hand ≤ 31; FAS ≤ 31; Animals ≤ 29). 
 
 EVI Failure and Group Membership. A between-subjects ANOVA was conducted to 
determine whether the number of liberal and conservative EVIs failed differed between the six 
groups (Table 8 and 9). The pattern of EVI failure was consistent between liberal and 
conservative cutoffs. For both, post-hoc analysis identified that EXPMAL and HAD groups failed 
significantly more EVIs than the other 4 groups but did not differ from each other. Those with 
MND failed more EVIs than controls, NN, or ANI. ANI failed significantly more EVIs than 
controls or NN. The number of EVIs failed did not differ between controls and NN.  
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Table 8 
Comparison of the total number of Liberal EVIs failed across groups 
 Total EVIs failed     
 n M SD F df p p2 
Control 44 1.0 1.2 50.58 5 .000 .42 
EXPMAL 21 4.2 2.4     
NN 227 0.82 0.9     
ANI 25 1.6 1.4     
MND 31 2.3 1.6     
HAD 8 4.4 1.1     
Note. EVI: Embedded validity indicator; EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively 
normal; ANI: Asymptomatic neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIV-
associated dementia. 
 
Table 9 
Comparison of the total number of Conservative EVIs failed across groups 
 Total EVIs failed     
 n M SD F df p p2 
Control 44 0.5 1.0 60.33 5 .000 .46 
EXPMAL 21 3.4 2.2     
NN 227 0.4 0.6     
ANI 25 1.0 0.9     
MND 31 1.7 1.5     
HAD 8 3.5 1.4     
Note. EVI: Embedded validity indicator; EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively 
normal; ANI: Asymptomatic neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIV-
associated dementia. 
 
 Table 10 presents the frequency distribution of the different profile validity 
classifications across groups. Regardless of cutoff, the majority of controls, NN, ANI, and MND 
participants produced valid profiles. In contrast, the majority of EXPMAL and HAD individuals 
produced invalid profiles. 
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Table 10 
Profile Validity Distribution of All Participants by Group 
  Liberal  Conservative 
 
Condition 
 
n 
Valid 
(2) 
Borderline 
(3) 
Invalid 
(4) 
 Valid 
(1) 
Borderline 
(2) 
Invalid 
(3) 
Control 44 40 1 3  40 1 3 
EXPMAL 21 4 5 12  5 4 12 
NN 227 219 5 3  213 12 2 
ANI 25 20 2 3  18 6 1 
MND 31 19 6 6  18 4 9 
HAD 8 0 2 6  1 1 6 
Total 356 302 21 33  295 28 33 
Note. EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively normal; ANI: Asymptomatic 
neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIV-associated dementia; Liberal cutoffs: 
Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux, 
2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & 
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning System (D-KEFS) 
Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved 
Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 33 (Erdodi, Seke, 
et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals ≤ 33 
(Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Conservative cutoffs: HVLT-R RD ≤ 7 
(Sawyer, Testa, & Dux, 2017); WCST FMS ≥ 1 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 
2003; Suhr & Boyer, 1999); D-KEFS Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, 
Hurtubise, et al., 2018); GPB dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31 
(Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); 
Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
  
 Significant differences were observed between group membership and the proportion of 
individuals failing EVIs at all liberal and conservative cutoffs investigated (Table 11 and 12). 
Individuals in the EXPMAL and HAD groups were consistently more likely to fail than pass 
cumulative EVI cutoffs, as indicated by risk ratios. In contrast, NN and controls were more likely 
to pass than fail EVIs at all cutoffs.   
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Table 11 
Percentage of Failure, Risk Ratio, and 2 analysis of all groups at ≥2, ≥3, and ≥4 liberal EVIs 
failed 
Criteria Condition % RR 2 p 2 
≥2 Control 29.5 0.4 89.71 < .001 .25 
EXPMAL 85.7 6.0    
NN 17.6 0.2    
ANI 52.0 1.1    
MND 67.7 2.1    
HAD 100.0 -    
≥3 Control 9.1 0.1 146.72 < .001 .41 
EXPMAL 76.2 3.2    
NN 3.5 <.1    
ANI 20.0 .3    
MND 38.7 .6    
HAD 100.0 -    
≥4 Control 6.8 .1 119.66 <.001 .34 
EXPMAL 57.1 1.3    
NN 1.3 <.1    
ANI 12.0 .1    
MND 19.4 .2    
HAD 75.0 3.0    
Note. EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively normal; ANI: Asymptomatic 
neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIV-associated dementia; Liberal cutoffs: 
Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux, 
2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & 
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning System (D-KEFS) 
Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved 
Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 33 (Erdodi, Seke, 
et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals ≤ 33 
(Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
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Table 12 
Percentage of Failure, Risk Ratio, and 2 analysis of all groups at ≥1, ≥2, and ≥3 Conservative 
EVIs failed 
Criteria Condition % RR 2 p 2 
≥1 Control 25.0 .3 79.58 <.001 .22 
 EXPMAL 95.2 20    
 NN 29.1 .4    
 ANI 68.0 2.1    
 MND 77.4 3.4    
 HAD 100.0 -    
≥2 Control 9.1 0.1 123.3 <.001 .35 
 EXPMAL 81.0 4.3    
 NN 6.2 .1    
 ANI 28.0 .4    
 MND 41.9 .7    
 HAD 87.5 7    
≥3 Control 6.8 .1 132.9 <.001 .37 
 EXPMAL 57.1 1.3    
 NN 0.9 <.1    
 ANI 4.0 <.1    
 MND 29.0 .4    
 HAD 75.0 3    
Note. EXPMAL: Experimental malingerers; NN: HIV+ and neurocognitively normal; ANI: Asymptomatic 
neurocognitively impaired; MND: Mild neurocognitive disorder; HAD: HIV-associated dementia; Conservative 
cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 7 (Sawyer, Testa, & 
Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 1 (King, Sweet, Sherer, Curtiss, & 
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning System (D-KEFS) 
Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018); Grooved 
Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31 (Erdodi, Seke, 
et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals ≤ 29 
(Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
 
 EVI Failure and Neuropsychological Test Performance. To test the influence of EVI 
failure on neuropsychological test performance in the HIV+ population, the undergraduate 
sample was removed. Further, the HAD group data was also removed as this population is 
known to have severe and genuine impairment that would increase EVI failure and reduce test 
performance (Davis, 2018). The remaining 4 groups (controls, NN, ANI, and MND) were 
merged and regrouped according to the total number of liberal and conservative EVIs failed. 
ANOVAs were conducted to explore group differences according to the total number of EVIs 
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failed (Table 13 and Table 14). Across all neuropsychological tests, the valid (liberal: ≤2; 
conservative: ≤1) and invalid (liberal: ≥4; conservative: ≥3) profile groups performed differently, 
with moderate to large effect sizes (d = .60-1.64). The borderline group (liberal: 3; conservative: 
2) had significantly poorer performance than the valid group on verbal fluency categories, 
HVLT-R total learning, HVLT-R delayed recall (liberal cutoff only), WCST categories 
completed, and SDMT. Neuropsychological test performance between the borderline and invalid 
groups never significantly differed.  
 
Table 13 
Comparison of Neuropsychological Test Performance across Levels of Liberal EVI Failure  
 Number of EVIs Failed      
 ≤2  3  ≥4      
 n = 258 
(91%) 
 n = 13 
(5%) 
 n = 12 
(4%) 
     
NP Test M SD  M SD  M SD F p ηp2 Sig. post hocs* d 
WRAT-4 105.0 12.7  94.8 14.1  91.4 13.1 10.03 <.001 .07 ≤2 vs. 3 .77 
            ≤2 vs. ≥4 1.01 
VFlu Cat 10.9 3.3  6.9 3.4  6.3 2.7 20.14 <.001 .13 ≤2 vs. 3 1.21 
            ≤2 vs. ≥4 1.56 
HVLT TL 42.1 10.8  31.0 6.5  29.9 7.7 13.81 <.001 .10 ≤2 vs. 3 1.24 
            ≤2 vs. ≥4 1.30 
HVLT DR 41.7 12.6  29.8 12.7  30.1 11.1 9.97 <.001 .07 ≤2 vs. 3 1.02 
            ≤2 vs. ≥4 1.07 
WCST Cat 3.3 1.4  2.1 1.4  2.4 0.8 7.55 .001 .05 ≤2 vs. 3 .91 
            ≤2 vs. ≥4 .81 
SDMT  0.04 1.0  -1.4 1.2  -1.4 .8 22.94 <.001 .14 ≤2 vs. 3 1.29 
            ≤2 vs. ≥4 1.57 
 
Note. EVI: Embedded validity indicator; WRAT-4: Wide Range Achievement Test – reading subtest scaled score 
(Wilkinson & Robertson, 2006); VFlu Cat: Verbal fluency categories scaled score (Delis, Kaplan, & Kramer, 2001); 
HVLT DR: Hopkins Verbal Learning Test - Revised delayed recall T-score (Brandt & Benedict, 2001); HVLT TL: 
Hopkins Verbal Learning Test - Revised total learning T-Score (Brandt & Benedict, 2001); WCST Cat: Wisconsin 
Card Sorting Test categories completed (Kongs, Thompson, Iverson, & Heaton, 2000); SDMT: Symbol Digit 
Modalities Test z-score (Smith. 1973); Liberal cutoffs: Hopkins Verbal Learning Test – Revised recognition 
discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain 
set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); 
Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 
≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); 
GPB non-dominant hand ≤ 33 (Erdodi, Seke, et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; 
Sugarman & Axelrod, 2015); Animals ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 
2015). 
 * Least significant difference (uncorrected t-tests) 
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Table 14 
Comparison of Neuropsychological Test Performance across Levels of Conservative EVI Failure  
 Number of EVIs Failed      
 ≤1  2  ≥3      
 n = 249  
(88%) 
 n = 22 
(8%) 
 n = 12  
(4%) 
     
NP Test M SD  M SD  M SD F p ηp2 Sig. post hocs* d 
WRAT-4 104.9 12.8  99.5 12.1  92.5 16.4 6.60 .002 .05 ≤1 vs. ≥3 .84 
VFlu Cat 11.0 3.3  8.1 3.4  5.9 2.4 20.28 <.001 .13 ≤1 vs. 2 .85 
            ≤1 vs. ≥3 1.77 
HVLT TL 42.2 10.8  36.1 9.8  27.8 6.9 13.18 <.001 .09 ≤1 vs. 2 .59 
            ≤1 vs. ≥3 1.59 
            2 vs. ≥3 .98 
HVLT DR 41.6 12.8  36.2 12.3  28.8 10.5 7.37 .001 .05 ≤1 vs. ≥3 1.10 
WCST Cat 3.3 1.4  2.7 1.5  2.3 0.8 5.49 .005 .04 ≤1 vs. 2 .45 
            ≤1 vs. ≥3 .97 
SDMT 0.1 1.0  -0.9 1.2  -1.7 1.0 25.32 <.001 .15 ≤1 vs. 2 .86 
            ≤1 vs. ≥3 1.83 
            2 vs. ≥3 .78 
 
Note. WRAT-4: Wide Range Achievement Test – reading subtest scaled score (Wilkinson & Robertson, 2006); 
VFlu Cat: Verbal Fluency categories scaled score (Delis, Kaplan, & Kramer, 2001); HVLT DR: Hopkins Verbal 
Learning Test revised delayed recall T-score (Brandt & Benedict, 2001); HVLT TL: Hopkins Verbal Learning Test 
revised total learning T-Score (Brandt & Benedict, 2001); WCST Cat: Wisconsin Card Sorting Test categories 
completed (Kongs, Thompson, Iverson, & Heaton, 2000); SDMT: Symbol Digit Modalities Test z-score (Smith. 
1973); Conservative cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 7 
(Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 1 (King, Sweet, 
Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning 
System (D-KEFS) Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018); 
Grooved Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31 
(Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); 
Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
 
 EVI Failure and Depression Symptom Endorsement. For these analyses, EXPMAL and 
HAD groups were removed. The remaining four groups (controls, NN, ANI, MND) were merged 
and divided into six new groups according to their raw PHQ-9 scores. Between subjects 
ANOVAs were used to determine whether PHQ-9 symptom ratings influenced EVI failure at 
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liberal or conservative cutoffs (Table 15 and 16). PHQ-9 raw scores did not influence EVI failure 
(p > .05).  
 
Table 15 
Comparison of the total number of Liberal EVIs failed across PHQ-9 Score groups 
 Total EVIs failed     
 n M SD F df p p2 
None 49 .92 1.1 1.12 5 .351 .017 
Minimal 118 .92 1.0     
Mild 87 1.3 1.3     
Moderate 51 1.1 1.3     
Moderately Severe 13 1.2 1.1     
Severe 8 1.4 1.3     
Note. EVI: Embedded validity indicator; None: PHQ-9 score of 0; Minimal: PHQ-9 score of 1-4; Mild PHQ-9 score 
of 5-9; Moderate: PHQ-9 score of 10-14; Moderately Severe: PHQ-9 score of 15-19; Severe: PHQ-9 score greater 
than 19 (Kroenke, Spitzer, & Williams, 2001); Liberal cutoffs: Hopkins Verbal Learning Test – Revised recognition 
discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain 
set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); 
Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 
≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); 
GPB non-dominant hand ≤ 33 (Erdodi, Seke, et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; 
Sugarman & Axelrod, 2015); Animals ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 
2015). 
 
 
Table 16 
Comparison of the total number of Conservative EVIs failed across PHQ-9 Score groups 
 Total EVIs failed     
 n M SD F df p p2 
None 49 0.5 0.8 1.415 5 0.22 0.22 
Minimal 118 0.4 0.7     
Mild 87 0.7 1.1     
Moderate 51 0.7 1.1     
Moderately Severe 13 0.7 0.8     
Severe 8 0.8 1.0     
Note. EVI: Embedded validity indicator; None: PHQ-9 score of 0; Minimal: PHQ-9 score of 1-4; Mild PHQ-9 score 
of 5-9; Moderate: PHQ-9 score of 10-14; Moderately Severe: PHQ-9 score of 15-19; Severe: PHQ-9 score greater 
than 19 (Kroenke, Spitzer, & Williams, 2001); Conservative cutoffs: Hopkins Verbal Learning Test – Revised 
recognition discrimination (HVLT-R RD) ≤ 7 (Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to 
maintain set (WCST FMS) ≥ 1 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 
1999); Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS 
Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018); Grooved Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 
2017); GPB non-dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 
2008; Sugarman & Axelrod, 2015); Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & 
Axelrod, 2015). 
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 A Chi-square test of independence was calculated comparing the proportion of 
individuals with invalid performance for each of the 6 PHQ-9 raw score groups at six cumulative 
cutoffs (Table 17 and 18). No significant interactions were observed between PHQ-9 raw scores 
and the level of liberal or conservative EVI failure.  
 
Table 17 
Proportion Failing, Risk Ratio, and 2 analysis according to Depressive Symptoms reported at 
≥2, ≥3, and ≥4 Liberal EVIs failed 
# of EVI 
failures 
Symptom 
endorsement 
% RR 2 p 2 
2 None 22.4 .3 3.79 .580 .11 
 Minimal 23.7 .3    
 Mild 33.3 .5    
 Moderate 23.5 .3    
 Mod. Sev 30.8 .4    
 Severe 37.5 .6    
3 None 6.1 .1 2.70 .747 .01 
 Minimal 6.8 .1    
 Mild 11.5 .1    
 Moderate 9.8 .1    
 Mod. Sev 15.4 .2    
 Severe 12.5 .1    
4 None 4.1 <.1 6.61 .252 .02 
 Minimal 1.7 <.1    
 Mild 8.0 .1    
 Moderate 5.9 .1    
 Mod. Sev 0 0    
 Severe 12.5 .1    
Note. EVI: Embedded validity indicator; None: PHQ-9 score of 0; Minimal: PHQ-9 score of 1-4; Mild PHQ-9 score 
of 5-9; Moderate: PHQ-9 score of 10-14; Mod. Sev: PHQ-9 score of 15-19; Severe: PHQ-9 score greater than 19 
(Kroenke, Spitzer, & Williams, 2001); Liberal cutoffs: Hopkins Verbal Learning Test – Revised recognition 
discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain 
set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); 
Delis-Kaplan Executive Functioning System (D-KEFS) Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 
≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); 
GPB non-dominant hand ≤ 33 (Erdodi, Seke, et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; 
Sugarman & Axelrod, 2015); Animals ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 
2015). 
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Table 18  
Proportion Failing, Risk Ratio, and 2 analysis according to Depressive Symptoms reported at 
≥1, ≥2, and ≥3 Conservative EVIs failed 
# of EVI 
failures 
Symptom 
endorsement 
% RR 2 p 2 
1 None 36.7 .6 6.24 .283 .08 
 Minimal 28.8 .4    
 Mild 41.4 .7    
 Moderate 37.3 .6    
 Mod. Sev 53.8 1.2    
 Severe 50 1    
2 None 12.2 .1 3.72 .59 .107 
 Minimal 7.6 .1    
 Mild 16.1 .2    
 Moderate 11.8 .1    
 Mod. Sev 15.4 .2    
 Severe 12.5 .1    
3 None 2.0 >.1 5.90 .316 .02 
 Minimal 2.5 >.1    
 Mild 6.9 .1    
 Moderate 7.8 .1    
 Mod. Sev 0 0    
 Severe 12.5 .1    
Note. None: PHQ-9 score of 0; Minimal: PHQ-9 score of 1-4; Mild PHQ-9 score of 5-9; Moderate: PHQ-9 score of 
10-14; Mod. Sev: PHQ-9 score of 15-19; Severe: PHQ-9 score greater than 19 (Kroenke, Spitzer, & Williams, 
2001); Conservative cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 7 
(Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 1 (King, Sweet, 
Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning 
System (D-KEFS) Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018); 
Grooved Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31 
(Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); 
Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
 
 Although raw scores provide insight into the frequency of depressive symptoms endorsed 
by participants, they are not indicative of symptom severity. Therefore, differences in the total 
number of EVIs failed was compared between four levels of symptom severity, as indicated by 
participants on Question 10 of the PHQ-9 (Table 19 and Table 20). Participants who endorsed no 
symptoms on questions 1-9 were excluded from the analysis. The level of symptom severity did 
not influence the number of total number of liberal or conservative EVIs failed.    
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Table 19 
Comparison of the total number of Liberal EVIs failed across PHQ-9 Distress groups 
 Total EVIs failed     
Level of Distress n M SD F df p p2 
Not Very Difficult 123 1.0 1.2 .744 3 .526 .008 
Somewhat Difficult 131 1.0 1.2     
Very Difficult 16 1.0 1.3     
Extremely Difficult 5 1.8 1.5     
Note. Level of distress as indicated by question 10 on the PHQ-9 (Kroenke, Spitzer, & Williams, 2001); Liberal 
cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 8 (Sawyer, Testa, & 
Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 2 (King, Sweet, Sherer, Curtiss, & 
Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning System (D-KEFS) 
Trail 2 ≤ 6 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 7 (Erdodi, Hurtubise, et al., 2018); Grooved 
Pegboard Test (GPB) dominant hand ≤ 31 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 33 (Erdodi, Seke, 
et al., 2017); FAS ≤ 33 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); Animals ≤ 33 
(Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
 
 
Table 20 
Comparison of the total number of Conservative EVIs failed across PHQ-9 Distress groups 
 Total EVIs failed     
Level of Distress n M SD F df p p2 
Not Very Difficult 123 .46 .9 1.10 3 .349 .012 
Somewhat Difficult 131 .60 .9     
Very Difficult 16 .75 1.2     
Extremely Difficult 5 1.0 1.3     
Note. Level of distress as indicated by question 10 on the PHQ-9 (Kroenke, Spitzer, & Williams, 2001); 
Conservative cutoffs: Hopkins Verbal Learning Test – Revised recognition discrimination (HVLT-R RD) ≤ 7 
(Sawyer, Testa, & Dux, 2017); Wisconsin Card Sorting Test failure to maintain set (WCST FMS) ≥ 1 (King, Sweet, 
Sherer, Curtiss, & Vanderploeg, 2002; Larrabee 2003; Suhr & Boyer, 1999); Delis-Kaplan Executive Functioning 
System (D-KEFS) Trail 2 ≤ 5 (Erdodi, Hurtubise, et al., 2018); D-KEFS Trail 4 ≤ 6 (Erdodi, Hurtubise, et al., 2018); 
Grooved Pegboard test (GPB) dominant hand ≤ 29 (Erdodi, Seke, et al., 2017); GPB non-dominant hand ≤ 31 
(Erdodi, Seke, et al., 2017); FAS ≤ 31 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015); 
Animals ≤ 29 (Curtis, Thompson, Greve, & Biachini, 2008; Sugarman & Axelrod, 2015). 
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CHAPTER IV 
Discussion 
 Performance validity testing has been identified as a critical component of 
neuropsychological assessment (Board of Directors, 2007; Bush et al., 2005). However, EVI 
utility in an HIV+ population is yet to be explored. The objective of the current study was to 
begin investigating performance validity within a traditional neuropsychological HAND battery. 
To do this, the utility of several EVIs were examined within an undergraduate sample. 
Cumulative EVI failure was compared across six groups (e.g. controls, EXPMAL, NN, ANI, 
MND, and HAD).  The relationship between EVI failure and neurocognitive performance as well 
as self-reported depression was explored. 
 Within the present HAND battery, eight EVIs were identified that demonstrated 
acceptable signal detection profiles (AUC   .70) within the student sample. Consistent with our 
a priori hypothesis, the number of EVIs failed differed across the six groups, and was predictive 
of neuropsychological test scores within the HIV+ sample. Interestingly, and contrary to 
expectations, depression as measured by the PHQ-9 was independent of EVI failure. 
Determining EVI cutoffs using the student sample 
 The signal detection profiles of eight EVIs were explored prior to their application to the 
HIV+ sample. All individual EVIs were significant predictors of the criterion variable 
(experimental malingering or Pass/Fail status on the WCT),and produced a classification 
accuracy hovering around the Larrabee limit: .50 sensitivity at .90 specificity (Erdodi et al., 
2014). Failure of a single EVI is insufficient evidence of invalid performance (Boone, 2013; 
Rickards, Cranston, Touradji, & Bechtold, 2017). Therefore, participants were classified based 
on their cumulative EVI failures as valid (2 failures at liberal cutoffs; 1 failures at 
  
49 
conservative cutoffs), borderline (3 failures at liberal cutoffs; 2 failures at conservative cutoffs), 
or invalid (4 failures at liberal cutoffs; 3 failures at conservative cutoffs). The “indeterminate 
range” (i.e., borderline) has been recently introduced as a third category in the traditional binary 
classification system to formally acknowledge the inherent uncertainty in the performance 
validity assessment (Erdodi, 2017). 
 The present study supports the dual criterion model of EVI calibration, which suggests 
that multiple criterion PVTs should be used when calibrating an EVI to monitor potential 
instrumentation artifacts (Erdodi, Hurtubise, et al., 2018). Previous research suggested that the 
sensory modality and cognitive domain of a criterion PVT may inflate the sensitivity and 
specificity profile of an EVI with congruent features. Conversely, incongruence may lead to 
underestimating the classification accuracy (Erdodi, 2017; Erdodi & Roth, 2017).  
Indeed, the effect of domain specificity was observed in the current study. For example, 
the WCT appears to be a measure of word list learning and memory and has been validated as a 
free-standing PVT (Barhon, Batchelor, Meares, Chekaluk, & Shores, 2015; Davis, 2014; Erdodi, 
Kirsch, Lajiness-O’Neill, Vingilis, & Medoff, 2014; Erdodi et al., 2017; Pearson, 2009). Within 
the present study, the WCT had a strong relationship with HVLT-R, a measure of auditory verbal 
learning, memory, and recognition, and weaker relationships with D-KEFS Trails, a measure of 
visuomotor processing speed and cognitive flexibility. It is worth noting that a strong 
relationship was observed between the WCT and GPB-ND (a test of manual dexterity), which 
suggests that the domain/modality specificity effect may be more complex than initially 
proposed, or that the WCT is a robust instrument that provides an unbiased index of performance 
validity within the HAND battery.  
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The experimental malingering paradigm was used as an alternative criterion variable, as 
it theoretically circumvents this limitation by allowing examinees to decide on which tests they 
choose to “demonstrate impairment”. At the same time, the most notable weakness of 
experimental malingering as a criterion is the absence of any real external incentive to perform 
poorly while avoiding detection. As such, studies relying on this design have been criticized for 
inflating the classification accuracy of predictor PVTs by creating diagnostically pure groups 
with minimal overlap but little etiological validity. In this case, the signal detection model is 
applied to a measurement context that is unrealistically easy to characterize, thereby reducing its 
ecological validity. Indeed, cutoffs developed using the experimental malingering paradigm 
often fail to replicate (Rogers, 2008).  
Similarly, experimental malingering comes with unique threats to internal validity. 
Namely, researchers rely exclusively on participants’ ability and willingness to adhere to 
instructions. In reality, participants assigned to the control group often fail PVTs (An et al., 
2012; 2017; 2018), contaminating the valid group. Conversely, participants assigned to the 
experimental malingering group may not make a genuine effort to produce credible impairment. 
Indeed, large variability in participants’ execution of instructions was observed within the 
present study: the total number of EVI failures ranged from 0 to 8 regardless of whether liberal 
or conservative cutoffs were used. In other words, some made little-to-no attempt to appear 
impaired, while others excessively exaggerated deficits.  
In contrast, using the WCT provides an opportunity to operationalize valid versus invalid 
responding using a well-established instrument. Psychometric definitions of non-credible 
responding have the advantage of refraining from making specific (and often untestable) 
assumptions about the validity of a given neurocognitive profile. It also allows researchers to 
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correct for the shortcomings of the experimental malingering design, by psychometrically 
defining valid and invalid. Thus, it correctly reclassifies examinees who were supposed to 
malinger but didn’t and those who were supposed to perform at true ability but didn’t as valid 
and invalid, respectively. 
Hypothesis 1: EVI failure will vary according to group membership (EXPMAL= HAD  > 
MND = ANI > NN = CON). 
 As hypothesized, between-group differences in cumulative EVI failure were observed. 
Controls and NN individuals had the fewest number of EVI failures, supporting the notion that 
EVI failure is insensitive to variations in education, age, and gender (An et al., 2012). On 
average, both controls and NN had cumulative EVI profiles that were classified as valid. HAD 
and EXPMAL groups failed the largest number of EVIs and produced invalid profiles at both 
liberal and conservative cutoffs. As mentioned, certain clinical populations, such as dementia, 
are exempt from PVTs due to genuine and severe neurological impairments that provide a more 
clinically accurate interpretation for a high number of PVT failures (Boone, 2013; Merten, 
Bossink, & Schmand, 2007).  
Although individuals diagnosed with ANI had a greater number of EVI failures than 
controls, they produced valid profiles, supporting the use of EVIs in HAND, as the validity 
cutoffs do not misclassify individuals with genuine mild cognitive deficits as non-credible. 
Individuals with MND had a greater number of EVI failures than those with ANI, and on 
average, produced valid profiles when liberal cutoffs were applied but borderline profiles when 
applying conservative cutoffs. These findings suggest that individuals with MND can be 
effectively protected against being misclassified as non-credible using more liberal multivariate 
cutoffs, but they are vulnerable to false positive errors if conservative cutoffs are applied. 
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Nevertheless, the elevated mean number of EVI failures in this group suggests that the 
neurocognitive profiles of individuals with MND are at a higher risk for being misclassified as 
invalid. Therefore, the issue of false positives in this population warrants further investigation. 
 Differentiating invalid responding from genuine impairment is beyond the scope of the 
present study. However, a strong linear relationship between the severity of cognitive 
impairment and EVI failure was observed within the HIV+ sample (HAD > MND > ANI > NN; 
Antinori et al., 2007). Although the true nature and clinical interpretation of this dose-response 
relationship remains unclear, there are three potential explanations.  
First, as EVIs are contained within ability tests, they are more prone to false positives in 
individuals with genuine cognitive impairments (Boone, 2013; DeRight & Carone, 2015). 
Therefore, the increasing number of EVI failures with HAND severity may reflect an elevated 
rate of false positives. Alternatively, the criteria used to determine an individual’s HAND 
diagnosis may have been contaminated by non-credible responding, such that invalid 
performance resulted in the misclassification of an individual’s cognitive profile as impaired. 
Lastly, rather than due to cognitive performance, the relationship between HAND severity and 
EVI failure may result from a secondary variable (e.g. pain, fatigue, depression, complex trauma 
history) that is commonly comorbid with HAND severity and accompanies increased risk of EVI 
failure (Bigler, 2014).    
Hypothesis 2: Those failing a greater number of EVIs will perform more poorly on 
neuropsychological tests. 
 A persistent concern in performance validity assessment is that elevated BRFail is a 
consequence of false positives in neurocognitively impaired individuals (Bigler, 2014). To 
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investigate this idea, only individuals diagnosed as NN, ANI, and MND were included within the 
analysis.  
Overall, individuals with valid profiles outperformed those with invalid profiles on six 
measures of cognitive ability. The cognitive profiles of the borderline cases tended to present 
more similarly to invalid, rather than valid, profiles, as reported previously (Erdodi, 2017). 
Taken together, the findings suggest that an inverse relationship exists between neurocognitive 
performance and EVI failure, replicating previous studies in undergraduates (An, Zakzanis, and 
Joordens, 2012; DeRight and Jorgensen, 2015), mixed clinical samples (Erdodi, Abeare, et al., 
2017), and non-litigating epilepsy surgery candidates (Loring, Lee, & Meador, 2004).  
 EVIs are contained within neuropsychological tests. Therefore, collinearity (i.e., shared 
error variance) cannot be fully eliminated, as the same test is used to measure both cognitive 
ability and performance validity. Within the present study, all variables that were used as validity 
indicators were excluded from this analysis. The limited number of tests within the HAND 
battery required some cognitive measures to be derived from other variables within a given test 
(e.g. verbal fluency categories, HVLT-R total learning, HVLT-R delayed recall, and WCST 
categories). Within these cognitive measures, the relationship between cognitive ability and EVI 
failure may also be influenced by collinearity. However, the WRAT-4 reading subtest and 
SDMT did not contain any EVIs. Although it is impossible to completely separate different 
cognitive domains, the WRAT-4 reading subtest emphasizes a domain (e.g. reading) not 
contained within the other neuropsychological tests within the battery. Valid profiles 
outperformed borderline and invalid profiles on the WRAT-4 and SDMT, suggesting that 
individuals who fail a greater number of EVIs are more likely to have impaired scores in general, 
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rather than in a domain, modality, or test-specific manner, reinforcing the global deleterious 
effect of non-credible responding (Boone, 2013; Larrabee, 2012). 
Hypothesis 3: Regardless of HIV status, individuals who have elevated PHQ-9 scores will 
fail more EVIs than those who do not. 
 An alternate explanation for Hypothesis 1 is that a third variable, such as depression, may 
account for between-group differences in EVI failure. It was hypothesized that individuals 
reporting more symptoms of depression would fail a greater number of EVIs. This prediction 
was not supported by the data: no relationship was observed between PHQ-9 scores and EVI 
failure. Further, in those reporting elevated levels of depression, symptom severity was 
independent of total EVI failures.  
Previous research suggested BRFail is related to emotional distress, somatic concerns, 
fatigue, pain, sensory disturbances, and limited English proficiency (Erdodi, Seke et al., 2017; 
Erdodi, Nussbaum, et al., 2017; Erdodi et al., 2016;  Greher & Wodushek, 2017, Whiteside et al., 
2010). Further, PVT failure has been linked to depression defined by a score of 19 on the Beck 
Depression Inventory-II (BDI-II; McCormick, Yoash-Gantz, McDonald, Campbell, & Tupler, 
2013). However, similar to our study, An, Zakzanis, and Joordens (2012) found no difference 
between valid and invalid profiles on the BDI in a student sample. The inconsistent relationship 
between self-reported depression and PVT failure may reflect methodological differences. 
Clinical depression is often comorbid with neurological problems (Christopher & MacDonald, 
2010), and can even manifest as cognitive deficits in individuals without neurological disorders. 
Indeed, certain defining features of depression (psychomotor retardation, low energy, diminished 
ability to think and concentrate, indecisiveness; American Psychiatric Association, 2013) can 
manifest as impairment on neuropsychological testing (i.e., low visuomotor speed and slow 
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simple reaction time, attention, working memory). Therefore, when comparing PVT failures 
between those with probable depression and those without as done by McCormick and 
colleagues (2013), genuine cognitive impairments may inflate BRFail. In contrast, the present 
study and that conducted by An and colleagues (2012) investigated PVT failure across a 
continuum of depressive symptoms and may not have captured clinical impairments related to 
depression.    
Limitations 
Several limitations within the present study reduce the generalizability of its findings. 
The most notable is the use of an HIV- undergraduate sample to determine the signal detection 
profile and cutoff scores of EVIs in an HIV+ population. In contrast to the HIV+ sample, 
undergraduates were younger, more educated, and comprised of a greater proportion of females. 
Although theoretically resistant to their influences, the demographic variables of the student 
sample may have produced inappropriately liberal cutoffs when applied to the HIV+ sample. 
However, as neurocognitive tests and EVI cutoffs primarily utilize scales that correct for age, 
education, and gender it is unlikely that such factors (e.g. cognitive reserve) would influence the 
findings of the present study. An additional demographic variable not taken into consideration is 
limited English proficiency. As English proficiency increases the risk of EVI failure, 
undergraduate and HIV+ group differences may reduce the translatability of the EVIs (Erdodi, 
Nussbaum, et al., 2017). A related limitation is the lack of free-standing PVTs included within 
the HAND battery. Free-standing PVTs are designed to estimate response credibility and are 
much less sensitive to genuine impairment than EVIs (Greher & Wodushek, 2017).  Their 
inclusion within the HAND battery would provide several PVT criteria to determine sensitivity 
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and specificity of EVI cutoffs within the HIV+ sample. Further, free-standing PVTs would 
provide EVI-independent insight into the credibility of a response set on a case-by-case basis.  
A general limitation to HAND research is the way HAND status is assigned. Functional 
impairments are determined via self-report measures. These measures ultimately distinguish 
between ANI and MND groups (Antinori et al., 2007). Without an objective measure of 
functional changes, patient descriptions of subjective experiences may create artificial group 
differences. 
Future Directions 
 The present study addressed limitations of previous PVT research using a single-blind 
paradigm in the undergraduate sample (An, Zakzanis, & Joordens, 2012) and relying on multiple 
criterion PVT. However, the current study is not without limitation. The data collected from the 
HIV+ population were archival and included no criterion PVT. Therefore, the signal detection 
analyses for EVIs within the HAND battery could not be extended to the HIV+ population. 
Future studies investigating cognitive functioning within the HAND population should include 
free-standing PVTs to allow researchers to address the collinearity issue (i.e., the confluence of 
genuine impairment and non-credible responding) and improve the internal validity of signal 
detection analyses.  
The relationship between neurocognitive performance and EVI failure was confounded 
by collinearity in all but two tests. By including several independent tests encompassing a variety 
of cognitive domains, future studies could explore whether EVI failure and cognitive 
impairments occur in a domain-specific or random pattern. If the EVIs failed are restricted to 
tests assessing performance within a single cognitive domain, then it is likely that non-credible 
profiles are a consequence of inflated false positive rates. Thus, future research in this area 
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would be supported by validating EVIs using HIV+ samples and increasing the number of 
neurocognitive tests included within the battery. In the meantime, for clinical purposes, at least 
two free-standing PVTs should be routinely administered in addition to the standard HAND 
battery, consistent with the recommendations of professional organizations (Bush et al., 2005; 
Heilbronner et al., 2009). 
Summary and Conclusions 
 The present study is the first to demonstrate that BRFail varies on EVIs within the HAND 
battery as a function of classification severity in an HIV+ population. These results may reflect 
elevated false positives due to genuine cognitive impairment or due to a third unmeasured 
variable. Worth mentioning, although the number of EVIs failed differed between groups, the 
average individual from NN and ANI groups was classified as having a valid profile. Although 
EVIs have been validated as a means to determine non-credible responding in several clinical 
populations, they are considered inappropriate in others (i.e. intellectual disability and dementia; 
Davis, 2018; Shandera et al., 2010). Thus, HAD populations should be excempt from 
performance validity testing. It is too early to determine whether MND due to HIV+ should be 
added to the list of exempt categories, but it warrants further empirical research.  
Even in populations where EVI use is recommended, other factors besides invalid 
performance have been identified as contributing to EVI failure including alterations in white 
matter integrity (Clark et al., 2016), pain, and sleep (Johnson-Greene, Brooks, & Ference, 2013). 
All three of these factors are prevalent in HIV+ populations and may contribute to increased risk 
of EVI failure. The present study suggests that it is unlikely that the factor underlying increased 
EVI failure is depression.  
  
58 
 In contrast, the relationship between EVI failure and HAND diagnosis may be due to 
invalid performance resulting in lower cognitive test scores and a more severe clinical diagnosis. 
Over a one year period, cognitive impairment levels fluctuate in almost half of individuals 
diagnosed with HAND (Antinori et al., 2007). If invalid responding is the true cause of low 
scores (rather than genuine impairment), it could provide an explanation for these fluctuations in 
the cognitive profile. The general relationship between cognitive impairment and EVI failure 
may support this hypothesis but further research is required, given the clinical implications of the 
conclusion (fluctuations of test taking effort vs. cognitive ability). 
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APPENDIX A: INTAKE QUESTIONNAIRE  
Gender: Female  Male  Other  
Age: _________________ 
Handedness: Right   Left   Ambidextrous  (i.e., able to use both hands with equal ease) 
Years of Education: _________ 
 
1. Have you ever been diagnosed with one of the following? 
 
a) Neurological disorder (e.g. stroke, multiple sclerosis)?  
Yes  No  
 
b) Have you ever had a traumatic brain injury or concussion? 
      Yes  No  
 
2. Are you currently experiencing severe anxiety, depression, manic symptoms? 
 
Yes  No  
 
3. Do you have a history of trauma? 
 
Yes  No  
 
If yes, physical   emotional    sexual   prefer not to say  
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APPENDIX B.1: INSTRUCTIONS FOR SIMULATED MALINGERING GROUP 
 
Imagine that you were in a car accident in which another driver hit your car. You were 
knocked unconscious, and woke up in the hospital. The doctors told you that you had some 
bleeding in your brain after the accident. 
Because the other driver is at fault, you have decided to take legal action against the 
driver. Your lawyer said that you may get more money if you look like you have sustained 
significant injuries because of the accident. You have decided to fake or exaggerate symptoms of 
a brain injury in order to increase the settlement you will receive. You have been told that 
common symptoms after a brain injury include difficulties with memory, concentrating, and 
being slower in responding. 
The other driver’s lawyer requires you to complete cognitive testing to determine if you 
sustained significant symptoms because the car accident. You know you can win a better 
settlement if you can convince the examiner that you have experienced significant brain damage. 
But if the examiner detects that you are faking, you are likely to lose the lawsuit.  
You are about to take a series of cognitive tests that would be used in such a situation. I 
would like you to pretend you have brain damage, but in a believable way, such that your 
examiner cannot tell that you are attempting to fake a brain injury. 
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APPENDIX B.2: INSTRUCTIONS FOR NON-MALINGERING GROUP 
You are about to take a series of cognitive tests. Some of the tests are easy and some are 
hard. I would like you to try your best on all of the tests. 
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APPENDIX C.1: POST-SESSION QUESTIONNAIRE FOR NON-MALINGERING 
CONTROL CONDITION 
Discuss briefly what you were asked to do in this study: 
 
 
 
 
How much did you try to follow the instructions during testing? 
           0 ---------1---------2---------3---------4---------5---------6---------7---------8---------9---------10 
Did not try at all        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tried my 
absolute best 
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APPENDIX C.2 POST-SESSION QUESTIONNAIRE FOR SIMULATED MALINGERING 
CONDITION 
Discuss briefly what you were asked to do in this study: 
 
 
 
How much did you try to follow the instructions during testing? 
           0 ---------1---------2---------3---------4---------5---------6---------7---------8---------9---------10 
Did not try at all        
 
How much could you imagine or relate to the motor vehicle accident scenario described? 
           0 ---------1---------2---------3---------4---------5---------6---------7---------8---------9---------10 
Not at all        
 
What did you do during testing to pretend that you had cognitive difficulties? (circle as many as 
applies) 
A. I responded to questions and completed tasks slower than usual 
B. I answered questions incorrectly even though I knew the answer 
C. I acted confused on how to complete the task 
D. I asked the examiner to repeat questions 
E. I didn’t follow the test instructions 
F. I didn’t pretend 
G. Other: ____________________________________________ 
 
 
 
 
 
 
Tried my 
absolute best 
I could imagine 
it very vividly 
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